Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of the AcRIS study is to obtain data to characterize the relationship between symptoms and voice features for (reverse transcription polymerase chain reaction (RT-PCR) confirmed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), influenza virus, or Respiratory Syncytial Virus (RSV) positive participants with acute viral respiratory illness. This data will be used as the basis to build voice and symptom algorithm(s) for detection and monitoring of these illnesses. This would benefit vaccine development across several key disease areas, including SARS-CoV-2, influenza virus and RSV.
The study also models concepts of more efficient "flexible" clinical trials involving not only voice capture, but also web-based participant recruitment, enhanced participant engagement, and remote sample collection that could make future clinical studies more efficient. The clinical data obtained in this observational study could provide the documentation of the technology's performance needed to enable its deployment in future interventional studies.
Each subject will be required to stay in the study for 6 weeks. If the participant tests positive for any of the three viruses at swab #1 or swab #2, they will continue the study until the end of Week 8.
Participants will record acute respiratory illnesses symptoms and voice data daily for up to a maximum of 8 weeks in both the well state and, should they become ill, the sick state, utilizing the Electronic diary on their Mobile application. Once enrolled, the participant will start recording symptoms and voice in the Electronic diary, with daily time commitment to this portion of the study expected to be 2-4 minutes. Two nasal self-swab collection kits will be ordered for delivery to the participant once they are enrolled in the study. The participant will be asked to self-swab when the test kit arrives (swab #1). The kit, including the specimen, will be returned to the central lab for RT-PCR SARS-CoV2/Influenza/RSV RT-PCR testing. The participant is expected to complete 3 phonemes and 5 lines of reading each day, in addition to score the self-reported symptoms in the Electronic diary. If participants become sick (self-report) with new or increased symptoms of acute respiratory illness symptoms, they will be asked to self-swab (swab #2) and return the sample for central SARS-CoV-2/Influenza/RSV RT-PCR testing. If the participant does not develop any new or increased symptoms between swab #1 and end of Week 6, they will obtain a self-swab (swab #2) at Day 42.
If the participant tests positive for any of the three viruses at swab #1 or swab #2, they will continue the study until end of week 8. If they test negative for the three viruses at swab #1 and swab #2, they will exit the study at approximately the end of week 6 when the test results are returned. The results of the RT-PCR testing will be shared with participants.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| All participants |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| SARS-CoV-2/Influenza/RSV RT-PCR | Diagnostic Test | nasal swab |
|
| Measure | Description | Time Frame |
|---|---|---|
| Change From Baseline in Self-Reported Symptom Scores From Well-to-Sick State Through Day 56 | Symptoms (fever, cough, difficult breathing, fatigue, runny nose, stuffy/blocked nose, sore throat, loss of taste/smell, chills, muscle pain, diarrhea, vomiting, headache, nausea, rigors, wheezing) recorded at least once daily in e-diary for 8 weeks & rated 0:none to 4:severe for fever & 0:none to 7:severe for other symptoms. Total symptom score=sum of all symptom scores in a recording session & mean of daily total symptom score=average across available sessions for each day, range=0 to 109, higher value=more severe total symptoms. Baseline=average of values up to 7 days before 1st occurrence of new/increased symptoms. If no data in 7 days, average of endpoint values for closest 3 days prior to 7 days used as baseline. Linear mixed effect model used for analysis for change from baseline in each symptom versus day during well to sick period, with slope (without intercept) included as fixed effects and random effects. Fixed effect of slope, as population level estimate, was reported. | Baseline up to Day 56 |
| Change From Baseline in Voice Features (AHH_Max Phonation Time, EE_Jitter Local Absolute, MM_Jitter Local Absolute) Values From Well-to-Sick State Through Day 56 | Participants recorded voice features such as pitch, jitter once daily in an electronic diary for 8 weeks. Voice assessments were done by 2 phonemes: 'eee' and 'mmm' for 4 seconds (minimum 3 seconds), 1 phoneme: "ahh" sustained (as long as possible) and a 5-sentence reading passage. Max Phonation Time: duration that sound is held for. Jitter Local Absolute: average absolute difference between consecutive periods. Indicates how unsteady the pitch is across neighboring glottal pulses. Linear mixed effect model was used for analysis for change from baseline in each voice feature versus day during the well to sick period, with slope (without intercept) included as fixed effects and random effects. The fixed effect of the slope, as the population level estimate, was reported. The data given has exponential factor in addition to values mentioned. Individual exponential factors have been mentioned in respective row title. | Baseline up to Day 56 |
| Change From Baseline in Voice Feature (Cepstral Peak Prominence, Harmonicity, MFCC Mean, MFCC Std, SNR, Shimmer Local dB, Spectral Flatness, Third Octave Band, and VLHR) Values From Well-to-Sick State Through Day 56 |
| Measure | Description | Time Frame |
|---|---|---|
| Percentage of Compliant Days in Total Days of Symptoms and Total Days of Voice Recordings Entered in the Electronic Diary | In this outcome measure, percentage of compliant days in total days of self-reported symptoms and total days of voice recordings as entered in the electronic diary were reported. Compliant days were calculated for the following and expressed as percentage: symptom compliance = number of compliant days of self-reported symptoms divided by the total number of days in the study. Voice compliance (expressed as percentage) = number of compliant days of completed voice recordings divided by the total number of days in the study. Partial voice compliance (expressed as percentage) = number of compliant days of partially completed voice recordings divided by the total number of days in the study. Symptom and voice compliance (expressed as percentage) = number of compliant days of self-reported symptoms and completed voice recordings divided by the total number of days in the study. Participants who experienced technical issues due to study operational errors were excluded. |
Not provided
Inclusion Criteria:
Participants are eligible to be included in the study only if all of the following criteria apply:
Age and Sex:
Male or female participants ≥18 years of age (or the minimum state specific age of consent if >18), at Screening visit.
Type of Participant and Disease Characteristics:
Participants who are willing and able to comply with daily symptom and voice assessments on the electronic diary application and other study procedures, including self-collection of nasal swabs.
Expected to be available for the duration of the study.
Informed Consent:
4. Capable of giving signed informed consent
-
Exclusion Criteria:
Participants are excluded from the study if any of the following criteria apply:
Participants who self-report any medical condition, recreational substance use, or medication use which would prevent them from completing study tasks or impair the providing of informed consent, or in the investigator's judgment, make the participant inappropriate for the study.
Prior/Concomitant Therapy:
Participants who have been vaccinated with COVID-19 vaccine or are planning to get vaccinated during study participation.
Participants can continue to use all other prescription or non-prescription medications.
Prior/Concurrent Clinical Study Experience:
Previous vaccination with any licensed or investigational RSV vaccine or are planning to get vaccinated during study participation.
Previous administration with an investigational drug within 30 days of enrollment (or as determined by the local requirement) or planning to participate in an interventional trial during study conduct.
Diagnostic Assessments:
Screening diagnostic assessments are not required for eligibility purposes.
Other Exclusions:
Investigator site staff or Pfizer employees directly involved in the conduct of the study, site staff otherwise supervised by the investigator including vendors, and their respective family members.
Participants who use a mobile device that does not meet the minimum requirements of the Electronic diary.
Participants who have previously been enrolled in the study cannot be re-enrolled.
Not provided
Not provided
Not provided
Planned enrollment of approximately 8700 participants 18 years of age or older in order to have a total of N of 100 participants with (1) confirmed negative SARS-CoV-2, RSV or Influenza RT-PCR (swab #1) and (2) confirmed positive SARS-CoV-2 RT-PCR, influenza virus or RSV (swab #2) symptomatic completers.
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Pfizer CT.gov Call Center | Pfizer | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Ochsner Clinic Foundation | New Orleans | Louisiana | 70121 | United States |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 40555587 | Derived | Chappie K, Kell S, Qi D, Selig J, Christakis Y, Moreno X, Severson J, Best A, Wacnik P, Santamaria M, Zhang Y, Fry BA, Mather RJ. Comparing Phoneme Speech Recordings and Acoustic App Data Capture Experience for Android and iOS Mobile Device Users in the Large Decentralized AcRIS Study. J Voice. 2025 Jun 23:S0892-1997(25)00201-2. doi: 10.1016/j.jvoice.2025.05.016. Online ahead of print. | |
| 40210993 |
| Label | URL |
|---|---|
| To obtain contact information for a study center near you, click here. | View source |
Not provided
Pfizer will provide access to individual de-identified participant data and related study documents (e.g. protocol, Statistical Analysis Plan (SAP), Clinical Study Report (CSR)) upon request from qualified researchers, and subject to certain criteria, conditions, and exceptions. Further details on Pfizer's data sharing criteria and process for requesting access can be found at: https://www.pfizer.com/science/clinical\_trials/trial\_data\_and\_results/data\_requests.
Not provided
Not provided
Not provided
Not provided
Not provided
This was an observational study involving collection of voice and respiratory symptoms data in participants in both the well state and sick state.
Not provided
| ID | Title | Description |
|---|---|---|
| FG000 | All Participants | Eligible participants aged 18 years and older recorded acute respiratory illnesses symptoms and voice data daily for up to a maximum of 8 weeks in both the well state and sick state, utilizing the electronic diary on their mobile application. Additionally, participants who performed two nasal self-swabs and the participants who tested positive for any of the three viruses (severe acute respiratory syndrome cornonavirus-2 [SARS-CoV-2], influenza virus and respiratory syncytial virus) at swab1 or swab 2, continued the study until end of Week 8. The participants who tested negative for the three viruses at swab 1 and swab 2, exited the study at end of Week 6. |
| Title | Milestones | Reasons Not Completed | ||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Overall Study |
|
|
Full analysis set included all participants who signed the informed consent document and were enrolled in the study.
Not provided
| ID | Title | Description |
|---|---|---|
| BG000 | All Participants | Eligible participants aged 18 years and older recorded acute respiratory illnesses symptoms and voice data daily for up to a maximum of 8 weeks in both the well state and sick state, utilizing the electronic diary on their mobile application. Additionally, participants who performed two nasal self-swabs and the participants who tested positive for any of the three viruses (severe acute respiratory syndrome cornonavirus-2 [SARS-CoV-2], influenza virus and respiratory syncytial virus) at swab1 or swab 2, continued the study until end of Week 8. The participants who tested negative for the three viruses at swab 1 and swab 2, exited the study at end of Week 6. |
| Units | Counts |
|---|---|
| Participants |
|
| Title | Description | Population Description | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Denominator Units Selected | Denominators | Classes |
|---|---|---|---|---|---|---|---|---|---|
| Age, Continuous | Mean |
| Type | Title | Description | Population Description | Reporting Status | Anticipated Posting Date | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Time Frame | Units Analyzed | Denominator Units Selected | Arm/Group Information | Denominators | Classes | Analyses |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Primary | Change From Baseline in Self-Reported Symptom Scores From Well-to-Sick State Through Day 56 | Symptoms (fever, cough, difficult breathing, fatigue, runny nose, stuffy/blocked nose, sore throat, loss of taste/smell, chills, muscle pain, diarrhea, vomiting, headache, nausea, rigors, wheezing) recorded at least once daily in e-diary for 8 weeks & rated 0:none to 4:severe for fever & 0:none to 7:severe for other symptoms. Total symptom score=sum of all symptom scores in a recording session & mean of daily total symptom score=average across available sessions for each day, range=0 to 109, higher value=more severe total symptoms. Baseline=average of values up to 7 days before 1st occurrence of new/increased symptoms. If no data in 7 days, average of endpoint values for closest 3 days prior to 7 days used as baseline. Linear mixed effect model used for analysis for change from baseline in each symptom versus day during well to sick period, with slope (without intercept) included as fixed effects and random effects. Fixed effect of slope, as population level estimate, was reported. | Participants who initially were SARS-CoV-2, Influenza and/or RSV negative (at Swab 1) and had no acute symptoms, and became SARS-CoV-2, Influenza virus or RSV positive (at Swab 2) and symptomatic during the study were included. Here, 'Overall Number of Participants Analyzed' signifies participants evaluable for this outcome measure and 'Number Analyzed' signifies participants evaluable for the specified rows. | Posted | Least Squares Mean | Standard Error | Scores on a scale |
Maximum up to Day 56
Not provided
Not provided
| ID | Title | Description | Deaths (Affected) | Deaths (At Risk) | Serious Events (Affected) | Serious Events (At Risk) | Other Events (Affected) | Other Events (At Risk) |
|---|---|---|---|---|---|---|---|---|
| EG000 | All Participants | Eligible participants aged 18 years and older recorded acute respiratory illnesses symptoms and voice data daily for up to a maximum of 8 weeks in both the well state and sick state, utilizing the electronic diary on their mobile application. Additionally, participants who performed two nasal self-swabs and the participants who tested positive for any of the three viruses (severe acute respiratory syndrome cornonavirus-2 [SARS-CoV-2], influenza virus and respiratory syncytial virus) at swab1 or swab 2, continued the study until end of Week 8. The participants who tested negative for the three viruses at swab 1 and swab 2, exited the study at end of Week 6. |
Not provided
| Term | Organ System | Source Vocabulary | Assessment Type | Notes | Statistical Information |
|---|---|---|---|---|---|
| Lacrimation increased | Eye disorders | MedDRA v25.0 | Non-systematic Assessment |
Not provided
| Title | Organization | Phone | Extension | |
|---|---|---|---|---|
| Pfizer ClinicalTrials.gov Call Center | Pfizer Inc. | 1-800-718-1021 | ClinicalTrials.gov_Inquiries@pfizer.com |
Not provided
| Type | Includes Protocol | Includes SAP | Includes ICF | Document Label | Document Date | Document Uploaded Date | Document File Name |
|---|---|---|---|---|---|---|---|
| Prot | Yes | No | No | Study Protocol | Sep 28, 2021 | Apr 17, 2023 | Prot_000.pdf |
| SAP | No | Yes | No | Statistical Analysis Plan | Jul 15, 2022 | Apr 17, 2023 | SAP_001.pdf |
Not provided
| ID | Term |
|---|---|
| D000086382 | COVID-19 |
| D018352 | Coronavirus Infections |
| D007251 | Influenza, Human |
| ID | Term |
|---|---|
| D011024 | Pneumonia, Viral |
| D011014 | Pneumonia |
| D012141 | Respiratory Tract Infections |
| D007239 | Infections |
Not provided
Not provided
Not provided
Not provided
Not provided
SARS-CoV-2/Influenza/RSV RT-PCR
Harmonicity, flatness, shimmer recorded and assessed by phonemes: 'eee' and 'mmm' for 4 seconds, "ahh" sustained and 5-sentence reading passage. Cepstral Peak Prominence: voice quality measure. Harmonicity: degree of periodicity in signal. mel frequency cepstral coefficients (MFCC) mean: quantifies shape of spectrum. MFCC std: quantifies variation in spectral shape over time. Signal-to-noise ratio (SNR): how loud signal is compared to background. Shimmer Local dB: average absolute difference between amplitudes of consecutive periods (how unsteady sound intensity is across neighboring glottal pulses). Spectral Flatness: quantifies how tone-like a signal is based on spectral distribution. Third Octave Band: energy in 200 Hz third octave band relative to total. VLHR: degree of nasality. Linear mixed effect model used for analysis. Fixed effect of slope, as population level estimate is reported. Individual exponential factors for data presented have been mentioned in respective row title. |
| Baseline up to Day 56 |
| Change From Baseline in Voice Feature (Coefficient of Variation, Mel Frequency Cepstral Coefficients (MFCC) 1st Order Delta, MFCC 2nd Order Delta) Values From Well-to-Sick State Through Day 56 | Voice features were recorded once daily in an electronic diary for 8 weeks. Assessments were done by 2 phonemes: 'eee' and 'mmm' for 4 seconds (minimum 3 seconds), 1 phoneme: "ahh" sustained (as long as possible) and a 5-sentence reading passage. Coefficient of Variation of F0: measures variation in pitch over time. MFCC 1st order delta: time-averaged estimate of first derivate of the MFCCs. MFCC 2nd order delta: time-averaged estimate of the second derivative of the MFCCs. Linear mixed effect model was used for analysis for change from baseline in each voice feature versus day during the well to sick period, with slope (without intercept) included as fixed effects and random effects. The fixed effect of the slope, as the population level estimate, was reported. The data given has exponential factor in addition to values mentioned. Individual exponential factors have been mentioned in respective row title. | Baseline up to Day 56 |
| Change From Baseline in Voice Features (EE_Entropy, MM_Entropy) Values From Well-to-Sick State Through Day 56 | Participants recorded voice features such as entropy once daily in an electronic diary for 8 weeks. Voice assessments were done by 2 phonemes: 'eee' and 'mmm' for 4 seconds (minimum 3 seconds), 1 phoneme: "ahh" sustained (as long as possible) and a 5-sentence reading passage. Entropy: Shannon entropy of the spectral distribution. Quantifies tonailty similar to spectral flatness. "EE_Entropy" and "MM_Entropy" refer to this same measure computed on the "eee" and "mmm" phonemes, respectively. Linear mixed effect model was used for analysis for change from baseline in each voice feature versus day during the well to sick period, with slope (without intercept) included as fixed effects and random effects. The fixed effect of the slope, as the population level estimate, was reported. The data given has exponential factor in addition to values mentioned. Individual exponential factors have been mentioned in respective row title. | Baseline up to Day 56 |
| Change From Baseline in Voice Features (Formant and Formant Bandwidth) Values From Well-to-Sick State Through Day 56 | Participants recorded voice features once daily in an electronic diary for 8 weeks. Voice assessments were done by 2 phonemes: 'eee' and 'mmm' for 4 seconds (minimum 3 seconds), 1 phoneme: "ahh" sustained (as long as possible) and a 5-sentence reading passage. Formant: frequency at which the vocal tract produces an acoustic resonance. Formant Bandwidth: the spectral width of the acoustic resonance. Linear mixed effect model was used for analysis for change from baseline in each voice feature versus day during the well to sick period, with slope (without intercept) included as fixed effects and random effects. The fixed effect of the slope, as the population level estimate, was reported. The data given has exponential factor in addition to values mentioned. Individual exponential factors have been mentioned in respective row title. | Baseline up to Day 56 |
| Change From Baseline in Voice Features (EE_Voiced Frames, MM_Voiced Frames) Values From Well-to-Sick State Through Day 56 | Participants recorded voice features once daily in an electronic diary for 8 weeks. Voice assessments were done by 2 phonemes: 'eee' and 'mmm' for 4 seconds (minimum 3 seconds), 1 phoneme: "ahh" sustained (as long as possible) and a 5-sentence reading passage. The voiced frames rate indicates how much of the sound is voiced. EE and MM refer to the sounds on which the measure is computed. Linear mixed effect model was used for analysis for change from baseline in each voice feature versus day during the well to sick period, with slope (without intercept) included as fixed effects and random effects. The fixed effect of the slope, as the population level estimate, was reported. The data given has exponential factor in addition to values mentioned. Individual exponential factors have been mentioned in respective row title. | Baseline up to Day 56 |
| Change From Baseline in Voice Features (EE_Jitter Local, MM_Jitter Local) Values From Well-to-Sick State Through Day 56 | Voice features such as jitter were recorded once daily in an electronic diary for 8 weeks. Voice assessments were done by 2 phonemes: 'eee' and 'mmm' for 4 seconds (minimum 3 seconds), 1 phoneme: "ahh" sustained (as long as possible) and a 5-sentence reading passage. Jitter Local: average absolute difference between consecutive periods divided by the average period as a percentage. Indicates how unsteady the pitch is across neighboring glottal pulses. Linear mixed effect model was used for analysis for change from baseline in each voice feature versus day during the well to sick period, with slope (without intercept) included as fixed effects and random effects. The fixed effect of the slope, as the population level estimate, was reported. The data given has exponential factor in addition to values mentioned. Individual exponential factors have been mentioned in respective row title. | Baseline up to Day 56 |
| Change From Baseline in Voice Features (EE_Shimmer Local, MM_Shimmer Local) Values From Well-to-Sick State Through Day 56 | Voice features such as shimmer were once daily in an electronic diary for 8 weeks. Voice assessments were done by 2 phonemes: 'eee' and 'mmm' for 4 seconds (minimum 3 seconds), 1 phoneme: "ahh" sustained (as long as possible) and a 5-sentence reading passage. Shimmer Local: average absolute difference between the amplitudes of consecutive periods divided by the average amplitude as a percentage. Indicates how unsteady the sound intensity is across neighboring glottal pulses. Linear mixed effect model was used for analysis for change from baseline in each voice feature versus day during the well to sick period, with slope (without intercept) included as fixed effects and random effects. The fixed effect of the slope, as the population level estimate, was reported. The data given has exponential factor in addition to values mentioned. Individual exponential factors have been mentioned in respective row title. | Baseline up to Day 56 |
| Change From Baseline in Voice Features (READ_Speaking Rate) Values From Well-to-Sick State Through Day 56 | Participants recorded voice features once daily in an electronic diary for 8 weeks. Voice assessments were done by 2 phonemes: 'eee' and 'mmm' for 4 seconds (minimum 3 seconds), 1 phoneme: "ahh" sustained (as long as possible) and a 5-sentence reading passage. Baseline was average of endpoint values up to 7 days before first occurrence of new/increased symptoms. If participant had no data in 7 days, average of endpoint values for closest 3 days prior to these 7 days was used as baseline. Linear mixed effect model was used for analysis for change from baseline in each voice feature versus day during the well to sick period, with slope (without intercept) included as fixed effects and random effects. The fixed effect of the slope, as the population level estimate, was reported. The data given has exponential factor (i.e. LSM*10^-2, SE*10^-3) in addition to values mentioned. | Baseline up to Day 56 |
| Day 1 up to Day 56 |
| Percentage of Quality Voice Recordings | In this outcome measure, percentage was calculated over the number of days that the participant was able to complete the task for each recording. Participants were required to record their daily voice in electronic diary and the assessment included 2 phonemes: 'eee' and 'mmm' for 4 seconds (minimum 3 seconds), 1 phoneme: "ahh" sustained (as long as possible) and a 5-sentence reading passage. Quality recordings were defined as recordings exceeding signal-to-noise (SNR) and duration thresholds (i.e. SNR >= 20 decibels [dB] that have duration >= 3 seconds for phoneme and >= 10 seconds for reading tasks). In the case of multiple electronic diary sessions per day, the session with the highest quality voice recordings for that day was used in this analysis. | Day 1 up to Day 56 |
| Percentage of Participants With a Positive Self-Swab Result for SARS-CoV-2 and/or Influenza and/or RSV | In this outcome measure, percentage of participants with valid self-swab 1 and 2 results positive for SARS-COV-2, Flu A, Flu B, RSV and SARS-CoV-2 and/or Influenza (Flu A/Flu B) and/or RSV were reported. | Day 2 up to Day 43 |
| Percentage of Participants Who Administered Self-swab 1 and Self-swab 2 | In this outcome measure, percentage of participants who administered self-swab 1, self-swab 2 and self-swab 1 and 2 excluding participants who experienced technical issues due to study operational errors were reported. | Day 2 up to Day 43 |
| Number of Days Between Reporting Symptoms and Recording Swab 2 in the Electronic-Diary | In this outcome measure, number of days from symptom onset (reporting new or increased symptoms in the electronic diary) to the day of recording Swab 2 day in the electronic diary averaged across participants who administered self-swab 2 was reported. | Day 2 Up to Day 43 |
| Percentage of Participants Reporting Symptoms in the Electronic Diary Who Have a Self-swab Collected at or Around Symptom Onset | In this outcome measure, 1) participants (par) who administered (adm) self-swab 2 (SS2) before Week 6 (W6) divided by the number of participants who reported new or increased (inc) symptoms (sym) in the electronic diary (e-diary) before W6 and 2) number of participants who reported new or increased symptoms in the e-diary before Week 6 divided by the number of participants who administered self-swab 2 before Week 6 were reported in percentage. | Day 2 Up to Day 43 |
| Percentage of Participants Who Administered Self-swabs With Valid Results | In this outcome measure, percentage of participants with valid (positive or negative) self-swab results for SARS-CoV-2, Flu A, Flu b and RSV were reported. | Day 2 Up to Day 43 |
| Derived |
| Santamaria M, Christakis Y, Demanuele C, Zhang Y, Tuttle PG, Mamashli F, Bai J, Landman R, Chappie K, Kell S, Samuelsson JG, Talbert K, Seoane L, Mark Roberts W, Kabagambe EK, Capelouto J, Wacnik P, Selig J, Adamowicz L, Khan S, Mather RJ. Longitudinal voice monitoring in a decentralized Bring Your Own Device trial for respiratory illness detection. NPJ Digit Med. 2025 Apr 11;8(1):202. doi: 10.1038/s41746-025-01584-4. |
| Lost to Follow-up |
|
| Years |
|
| Sex: Female, Male | Count of Participants | Participants |
|
| Ethnicity (NIH/OMB) | Count of Participants | Participants |
|
| Race (NIH/OMB) | Count of Participants | Participants |
|
| Baseline up to Day 56 |
|
|
|
|
| Primary | Change From Baseline in Voice Features (AHH_Max Phonation Time, EE_Jitter Local Absolute, MM_Jitter Local Absolute) Values From Well-to-Sick State Through Day 56 | Participants recorded voice features such as pitch, jitter once daily in an electronic diary for 8 weeks. Voice assessments were done by 2 phonemes: 'eee' and 'mmm' for 4 seconds (minimum 3 seconds), 1 phoneme: "ahh" sustained (as long as possible) and a 5-sentence reading passage. Max Phonation Time: duration that sound is held for. Jitter Local Absolute: average absolute difference between consecutive periods. Indicates how unsteady the pitch is across neighboring glottal pulses. Linear mixed effect model was used for analysis for change from baseline in each voice feature versus day during the well to sick period, with slope (without intercept) included as fixed effects and random effects. The fixed effect of the slope, as the population level estimate, was reported. The data given has exponential factor in addition to values mentioned. Individual exponential factors have been mentioned in respective row title. | Participants who initially were SARS-CoV-2, Influenza and/or RSV negative (at Swab 1) and had no acute symptoms, and became SARS-CoV-2, Influenza virus or RSV positive (at Swab 2) and symptomatic during the study. Here, 'Overall Number of Participants Analyzed' signifies participants evaluable for this outcome measure and 'Number Analyzed' signifies participants evaluable for the specified rows. | Posted | Least Squares Mean | Standard Error | Seconds | Baseline up to Day 56 |
|
|
|
|
| Primary | Change From Baseline in Voice Feature (Cepstral Peak Prominence, Harmonicity, MFCC Mean, MFCC Std, SNR, Shimmer Local dB, Spectral Flatness, Third Octave Band, and VLHR) Values From Well-to-Sick State Through Day 56 | Harmonicity, flatness, shimmer recorded and assessed by phonemes: 'eee' and 'mmm' for 4 seconds, "ahh" sustained and 5-sentence reading passage. Cepstral Peak Prominence: voice quality measure. Harmonicity: degree of periodicity in signal. mel frequency cepstral coefficients (MFCC) mean: quantifies shape of spectrum. MFCC std: quantifies variation in spectral shape over time. Signal-to-noise ratio (SNR): how loud signal is compared to background. Shimmer Local dB: average absolute difference between amplitudes of consecutive periods (how unsteady sound intensity is across neighboring glottal pulses). Spectral Flatness: quantifies how tone-like a signal is based on spectral distribution. Third Octave Band: energy in 200 Hz third octave band relative to total. VLHR: degree of nasality. Linear mixed effect model used for analysis. Fixed effect of slope, as population level estimate is reported. Individual exponential factors for data presented have been mentioned in respective row title. | Participants who initially were SARS-CoV-2, Influenza and/or RSV negative (at Swab 1) and had no acute symptoms, and became SARS-CoV-2, Influenza virus or RSV positive (at Swab 2) and symptomatic during the study. Here, 'Overall Number of Participants Analyzed' signifies participants evaluable for this outcome measure. | Posted | Least Squares Mean | Standard Error | Decibel | Baseline up to Day 56 |
|
|
|
|
| Primary | Change From Baseline in Voice Feature (Coefficient of Variation, Mel Frequency Cepstral Coefficients (MFCC) 1st Order Delta, MFCC 2nd Order Delta) Values From Well-to-Sick State Through Day 56 | Voice features were recorded once daily in an electronic diary for 8 weeks. Assessments were done by 2 phonemes: 'eee' and 'mmm' for 4 seconds (minimum 3 seconds), 1 phoneme: "ahh" sustained (as long as possible) and a 5-sentence reading passage. Coefficient of Variation of F0: measures variation in pitch over time. MFCC 1st order delta: time-averaged estimate of first derivate of the MFCCs. MFCC 2nd order delta: time-averaged estimate of the second derivative of the MFCCs. Linear mixed effect model was used for analysis for change from baseline in each voice feature versus day during the well to sick period, with slope (without intercept) included as fixed effects and random effects. The fixed effect of the slope, as the population level estimate, was reported. The data given has exponential factor in addition to values mentioned. Individual exponential factors have been mentioned in respective row title. | Participants who initially were SARS-CoV-2, Influenza and/or RSV negative (at Swab 1) and had no acute symptoms, and became SARS-CoV-2, Influenza virus or RSV positive (at Swab 2) and symptomatic during the study. Here, 'Overall Number of Participants Analyzed' signifies participants evaluable for this outcome measure. | Posted | Least Squares Mean | Standard Error | Unitless | Baseline up to Day 56 |
|
|
|
|
| Primary | Change From Baseline in Voice Features (EE_Entropy, MM_Entropy) Values From Well-to-Sick State Through Day 56 | Participants recorded voice features such as entropy once daily in an electronic diary for 8 weeks. Voice assessments were done by 2 phonemes: 'eee' and 'mmm' for 4 seconds (minimum 3 seconds), 1 phoneme: "ahh" sustained (as long as possible) and a 5-sentence reading passage. Entropy: Shannon entropy of the spectral distribution. Quantifies tonailty similar to spectral flatness. "EE_Entropy" and "MM_Entropy" refer to this same measure computed on the "eee" and "mmm" phonemes, respectively. Linear mixed effect model was used for analysis for change from baseline in each voice feature versus day during the well to sick period, with slope (without intercept) included as fixed effects and random effects. The fixed effect of the slope, as the population level estimate, was reported. The data given has exponential factor in addition to values mentioned. Individual exponential factors have been mentioned in respective row title. | Participants who initially were SARS-CoV-2, Influenza and/or RSV negative (at Swab 1) and had no acute symptoms, and became SARS-CoV-2, Influenza virus or RSV positive (at Swab 2) and symptomatic during the study. Here, 'Overall Number of Participants Analyzed' signifies participants evaluable for this outcome measure. | Posted | Least Squares Mean | Standard Error | Bit | Baseline up to Day 56 |
|
|
|
|
| Primary | Change From Baseline in Voice Features (Formant and Formant Bandwidth) Values From Well-to-Sick State Through Day 56 | Participants recorded voice features once daily in an electronic diary for 8 weeks. Voice assessments were done by 2 phonemes: 'eee' and 'mmm' for 4 seconds (minimum 3 seconds), 1 phoneme: "ahh" sustained (as long as possible) and a 5-sentence reading passage. Formant: frequency at which the vocal tract produces an acoustic resonance. Formant Bandwidth: the spectral width of the acoustic resonance. Linear mixed effect model was used for analysis for change from baseline in each voice feature versus day during the well to sick period, with slope (without intercept) included as fixed effects and random effects. The fixed effect of the slope, as the population level estimate, was reported. The data given has exponential factor in addition to values mentioned. Individual exponential factors have been mentioned in respective row title. | Participants who initially were SARS-CoV-2, Influenza and/or RSV negative (at Swab 1) and had no acute symptoms, and became SARS-CoV-2, Influenza virus or RSV positive (at Swab 2) and symptomatic during the study. Here, 'Overall Number of Participants Analyzed' signifies participants evaluable for this outcome measure. | Posted | Least Squares Mean | Standard Error | Hertz | Baseline up to Day 56 |
|
|
|
|
| Primary | Change From Baseline in Voice Features (EE_Voiced Frames, MM_Voiced Frames) Values From Well-to-Sick State Through Day 56 | Participants recorded voice features once daily in an electronic diary for 8 weeks. Voice assessments were done by 2 phonemes: 'eee' and 'mmm' for 4 seconds (minimum 3 seconds), 1 phoneme: "ahh" sustained (as long as possible) and a 5-sentence reading passage. The voiced frames rate indicates how much of the sound is voiced. EE and MM refer to the sounds on which the measure is computed. Linear mixed effect model was used for analysis for change from baseline in each voice feature versus day during the well to sick period, with slope (without intercept) included as fixed effects and random effects. The fixed effect of the slope, as the population level estimate, was reported. The data given has exponential factor in addition to values mentioned. Individual exponential factors have been mentioned in respective row title. | Participants who initially were SARS-CoV-2, Influenza and/or RSV negative (at Swab 1) and had no acute symptoms, and became SARS-CoV-2, Influenza virus or RSV positive (at Swab 2) and symptomatic during the study. Here, 'Overall Number of Participants Analyzed' signifies participants evaluable for this outcome measure. | Posted | Least Squares Mean | Standard Error | Frame per second | Baseline up to Day 56 |
|
|
|
|
| Primary | Change From Baseline in Voice Features (EE_Jitter Local, MM_Jitter Local) Values From Well-to-Sick State Through Day 56 | Voice features such as jitter were recorded once daily in an electronic diary for 8 weeks. Voice assessments were done by 2 phonemes: 'eee' and 'mmm' for 4 seconds (minimum 3 seconds), 1 phoneme: "ahh" sustained (as long as possible) and a 5-sentence reading passage. Jitter Local: average absolute difference between consecutive periods divided by the average period as a percentage. Indicates how unsteady the pitch is across neighboring glottal pulses. Linear mixed effect model was used for analysis for change from baseline in each voice feature versus day during the well to sick period, with slope (without intercept) included as fixed effects and random effects. The fixed effect of the slope, as the population level estimate, was reported. The data given has exponential factor in addition to values mentioned. Individual exponential factors have been mentioned in respective row title. | Participants who initially were SARS-CoV-2, Influenza and/or RSV negative (at Swab 1) and had no acute symptoms, and became SARS-CoV-2, Influenza virus or RSV positive (at Swab 2) and symptomatic during the study. Here, 'Overall Number of Participants Analyzed' signifies participants evaluable for this outcome measure. | Posted | Least Squares Mean | Standard Error | Percentage of period | Baseline up to Day 56 |
|
|
|
|
| Primary | Change From Baseline in Voice Features (EE_Shimmer Local, MM_Shimmer Local) Values From Well-to-Sick State Through Day 56 | Voice features such as shimmer were once daily in an electronic diary for 8 weeks. Voice assessments were done by 2 phonemes: 'eee' and 'mmm' for 4 seconds (minimum 3 seconds), 1 phoneme: "ahh" sustained (as long as possible) and a 5-sentence reading passage. Shimmer Local: average absolute difference between the amplitudes of consecutive periods divided by the average amplitude as a percentage. Indicates how unsteady the sound intensity is across neighboring glottal pulses. Linear mixed effect model was used for analysis for change from baseline in each voice feature versus day during the well to sick period, with slope (without intercept) included as fixed effects and random effects. The fixed effect of the slope, as the population level estimate, was reported. The data given has exponential factor in addition to values mentioned. Individual exponential factors have been mentioned in respective row title. | Participants who initially were SARS-CoV-2, Influenza and/or RSV negative (at Swab 1) and had no acute symptoms, and became SARS-CoV-2, Influenza virus or RSV positive (at Swab 2) and symptomatic during the study. Here, 'Overall Number of Participants Analyzed' signifies participants evaluable for this outcome measure. | Posted | Least Squares Mean | Standard Error | Percentage of amplitude | Baseline up to Day 56 |
|
|
|
|
| Primary | Change From Baseline in Voice Features (READ_Speaking Rate) Values From Well-to-Sick State Through Day 56 | Participants recorded voice features once daily in an electronic diary for 8 weeks. Voice assessments were done by 2 phonemes: 'eee' and 'mmm' for 4 seconds (minimum 3 seconds), 1 phoneme: "ahh" sustained (as long as possible) and a 5-sentence reading passage. Baseline was average of endpoint values up to 7 days before first occurrence of new/increased symptoms. If participant had no data in 7 days, average of endpoint values for closest 3 days prior to these 7 days was used as baseline. Linear mixed effect model was used for analysis for change from baseline in each voice feature versus day during the well to sick period, with slope (without intercept) included as fixed effects and random effects. The fixed effect of the slope, as the population level estimate, was reported. The data given has exponential factor (i.e. LSM*10^-2, SE*10^-3) in addition to values mentioned. | Participants who initially were SARS-CoV-2, Influenza and/or RSV negative (at Swab 1) and had no acute symptoms, and became SARS-CoV-2, Influenza virus or RSV positive (at Swab 2) and symptomatic during the study. Here, 'Overall Number of Participants Analyzed' signifies participants evaluable for this outcome measure. | Posted | Least Squares Mean | Standard Error | Syllable per second | Baseline up to Day 56 |
|
|
|
|
| Secondary | Percentage of Compliant Days in Total Days of Symptoms and Total Days of Voice Recordings Entered in the Electronic Diary | In this outcome measure, percentage of compliant days in total days of self-reported symptoms and total days of voice recordings as entered in the electronic diary were reported. Compliant days were calculated for the following and expressed as percentage: symptom compliance = number of compliant days of self-reported symptoms divided by the total number of days in the study. Voice compliance (expressed as percentage) = number of compliant days of completed voice recordings divided by the total number of days in the study. Partial voice compliance (expressed as percentage) = number of compliant days of partially completed voice recordings divided by the total number of days in the study. Symptom and voice compliance (expressed as percentage) = number of compliant days of self-reported symptoms and completed voice recordings divided by the total number of days in the study. Participants who experienced technical issues due to study operational errors were excluded. | Full analysis set included all participants who signed the informed consent document and enrolled in the study. Here, 'Overall Number of Participants Analyzed' signifies participants evaluable for this outcome measure. | Posted | Mean | Standard Deviation | Percentage of days | Day 1 up to Day 56 |
|
|
|
| Secondary | Percentage of Quality Voice Recordings | In this outcome measure, percentage was calculated over the number of days that the participant was able to complete the task for each recording. Participants were required to record their daily voice in electronic diary and the assessment included 2 phonemes: 'eee' and 'mmm' for 4 seconds (minimum 3 seconds), 1 phoneme: "ahh" sustained (as long as possible) and a 5-sentence reading passage. Quality recordings were defined as recordings exceeding signal-to-noise (SNR) and duration thresholds (i.e. SNR >= 20 decibels [dB] that have duration >= 3 seconds for phoneme and >= 10 seconds for reading tasks). In the case of multiple electronic diary sessions per day, the session with the highest quality voice recordings for that day was used in this analysis. | Full analysis set included all participants who signed the informed consent document and enrolled in the study. | Posted | Mean | Standard Deviation | Percentage of quality recordings | Day 1 up to Day 56 |
|
|
|
| Secondary | Percentage of Participants With a Positive Self-Swab Result for SARS-CoV-2 and/or Influenza and/or RSV | In this outcome measure, percentage of participants with valid self-swab 1 and 2 results positive for SARS-COV-2, Flu A, Flu B, RSV and SARS-CoV-2 and/or Influenza (Flu A/Flu B) and/or RSV were reported. | Full analysis set included all participants who signed the informed consent document and enrolled in the study. Here, 'Overall Number of Participants Analyzed' signifies participants evaluable for this outcome measure and 'Number Analyzed' signifies participants evaluable for the specified rows. | Posted | Number | Percentage of participants | Day 2 up to Day 43 |
|
|
|
| Secondary | Percentage of Participants Who Administered Self-swab 1 and Self-swab 2 | In this outcome measure, percentage of participants who administered self-swab 1, self-swab 2 and self-swab 1 and 2 excluding participants who experienced technical issues due to study operational errors were reported. | Full analysis set included all participants who signed the informed consent document and enrolled in the study. Here, 'Overall Number of Participants Analyzed' signifies participants evaluable for this outcome measure. | Posted | Number | Percentage of participants | Day 2 up to Day 43 |
|
|
|
| Secondary | Number of Days Between Reporting Symptoms and Recording Swab 2 in the Electronic-Diary | In this outcome measure, number of days from symptom onset (reporting new or increased symptoms in the electronic diary) to the day of recording Swab 2 day in the electronic diary averaged across participants who administered self-swab 2 was reported. | Full analysis set included all participants who signed the informed consent document and enrolled in the study. Here, 'Overall Number of Participants Analyzed' signifies participants had administered self swab 2 and were evaluable for this outcome measure. | Posted | Mean | Standard Deviation | Days | Day 2 Up to Day 43 |
|
|
|
| Secondary | Percentage of Participants Reporting Symptoms in the Electronic Diary Who Have a Self-swab Collected at or Around Symptom Onset | In this outcome measure, 1) participants (par) who administered (adm) self-swab 2 (SS2) before Week 6 (W6) divided by the number of participants who reported new or increased (inc) symptoms (sym) in the electronic diary (e-diary) before W6 and 2) number of participants who reported new or increased symptoms in the e-diary before Week 6 divided by the number of participants who administered self-swab 2 before Week 6 were reported in percentage. | Full analysis set included all participants who signed the informed consent document and enrolled in the study. Here, 'Overall Number of Participants Analyzed' signifies participants evaluable for this outcome measure and 'Number Analyzed' signifies participants evaluable for the specified rows. | Posted | Number | Percentage of participants | Day 2 Up to Day 43 |
|
|
|
| Secondary | Percentage of Participants Who Administered Self-swabs With Valid Results | In this outcome measure, percentage of participants with valid (positive or negative) self-swab results for SARS-CoV-2, Flu A, Flu b and RSV were reported. | Full analysis set included all participants who signed the informed consent document and enrolled in the study. Here, 'Overall Number of Participants Analyzed' signifies participants evaluable for this outcome measure and 'Number Analyzed' signifies participants evaluable for the specified rows. | Posted | Number | Percentage of participants | Day 2 Up to Day 43 |
|
|
|
| 0 |
| 9,151 |
| 0 |
| 9,151 |
| 28 |
| 9,151 |
| Abdominal pain upper | Gastrointestinal disorders | MedDRA v25.0 | Non-systematic Assessment |
|
| Diarrhoea | Gastrointestinal disorders | MedDRA v25.0 | Non-systematic Assessment |
|
| Nausea | Gastrointestinal disorders | MedDRA v25.0 | Non-systematic Assessment |
|
| Vomiting | Gastrointestinal disorders | MedDRA v25.0 | Non-systematic Assessment |
|
| Asthenia | General disorders | MedDRA v25.0 | Non-systematic Assessment |
|
| Chest discomfort | General disorders | MedDRA v25.0 | Non-systematic Assessment |
|
| Chills | General disorders | MedDRA v25.0 | Non-systematic Assessment |
|
| Fatigue | General disorders | MedDRA v25.0 | Non-systematic Assessment |
|
| Malaise | General disorders | MedDRA v25.0 | Non-systematic Assessment |
|
| Pain | General disorders | MedDRA v25.0 | Non-systematic Assessment |
|
| Pyrexia | General disorders | MedDRA v25.0 | Non-systematic Assessment |
|
| Myalgia | Musculoskeletal and connective tissue disorders | MedDRA v25.0 | Non-systematic Assessment |
|
| Spinal pain | Musculoskeletal and connective tissue disorders | MedDRA v25.0 | Non-systematic Assessment |
|
| Headache | Nervous system disorders | MedDRA v25.0 | Non-systematic Assessment |
|
| Migraine | Nervous system disorders | MedDRA v25.0 | Non-systematic Assessment |
|
| Dysmenorrhoea | Reproductive system and breast disorders | MedDRA v25.0 | Non-systematic Assessment |
|
| Cough | Respiratory, thoracic and mediastinal disorders | MedDRA v25.0 | Non-systematic Assessment |
|
| Dysphonia | Respiratory, thoracic and mediastinal disorders | MedDRA v25.0 | Non-systematic Assessment |
|
| Dyspnoea | Respiratory, thoracic and mediastinal disorders | MedDRA v25.0 | Non-systematic Assessment |
|
| Nasal congestion | Respiratory, thoracic and mediastinal disorders | MedDRA v25.0 | Non-systematic Assessment |
|
| Oropharyngeal pain | Respiratory, thoracic and mediastinal disorders | MedDRA v25.0 | Non-systematic Assessment |
|
| Rhinorrhoea | Respiratory, thoracic and mediastinal disorders | MedDRA v25.0 | Non-systematic Assessment |
|
| Sneezing | Respiratory, thoracic and mediastinal disorders | MedDRA v25.0 | Non-systematic Assessment |
|
| Rash | Skin and subcutaneous tissue disorders | MedDRA v25.0 | Non-systematic Assessment |
|
Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
| D014777 |
| Virus Diseases |
| D003333 | Coronaviridae Infections |
| D030341 | Nidovirales Infections |
| D012327 | RNA Virus Infections |
| D008171 | Lung Diseases |
| D012140 | Respiratory Tract Diseases |
| D009976 | Orthomyxoviridae Infections |
|
| MM_Jitter Local Absolute: LSM (10^-7) |
|
|
EE_Jitter Local Absolute (The statistical data given below have exponential factor in addition to the values mentioned. For estimated value it was 10^-8). |
| Mixed Models Analysis |
| <.0001 |
| Slope |
| 6.899 |
| Standard Error of the Mean |
| 0 |
| 2-Sided |
| 90 |
| Other |
| MM_Jitter Local Absolute (The statistical data given below have exponential factor in addition to the values mentioned. For estimated value it was 10^-7). | Mixed Models Analysis | <.0001 | Slope | -1.743 | Standard Error of the Mean | 0 | 2-Sided | 90 | Other |
|
| EE_MFCC mean 02 LSM (10^-1), SE (10^-1) |
|
| EE_MFCC mean 03 LSM (10^-1), SE (10^-1) |
|
| EE_MFCC mean 04 LSM (10^-1), SE (10^-1) |
|
| EE_MFCC mean 05 LSM (10^-3), SE (10^-2) |
|
| EE_MFCC mean 06 LSM (10^-1), SE (10^-2) |
|
| EE_MFCC mean 07 LSM (10^-1), SE (10^-2) |
|
| EE_MFCC mean 08 LSM (10^-1), SE (10^-2) |
|
| EE_MFCC mean 09 LSM (10^-2), SE (10^-2) |
|
| EE_MFCC mean 10 LSM (10^-2), SE (10^-2) |
|
| EE_MFCC mean 11 LSM (10^-2), SE (10^-2) |
|
| EE_MFCC mean 12 LSM (10^-4), SE (10^-2) |
|
| EE_MFCC mean 13 LSM (10^-3), SE (10^-2) |
|
| EE_MFCC std 01 LSM (10^-2), SE (10^-2) |
|
| EE_MFCC std 02 LSM (10^-2), SE (10^-2) |
|
| EE_MFCC std 03 LSM (10^-2), SE (10^-2) |
|
| EE_MFCC std 04 LSM (10^-2), SE (10^-2) |
|
| EE_MFCC std 05 LSM (10^-3), SE (10^-2) |
|
| EE_MFCC std 06 LSM (10^-2), SE (10^-3) |
|
| EE_MFCC std 07 LSM (10^-2), SE (10^-3) |
|
| EE_MFCC std 08 LSM (10^-2), SE (10^-3) |
|
| EE_MFCC std 09 LSM (10^-2), SE (10^-3) |
|
| EE_MFCC std 10 LSM (10^-2), SE (10^-3) |
|
| EE_MFCC std 11 LSM (10^-2), SE (10^-3) |
|
| EE_MFCC std 12 LSM (10^-2), SE (10^-3) |
|
| EE_MFCC std 13 LSM (10^-2), SE (10^-3) |
|
| EE_SNR LSM (10^-2), SE (10^-2) |
|
| EE_Shimmer Local dB LSM (10^-4), SE (10^-4) |
|
| EE_Spectral Flatness LSM (10^-2), SE (10^-2) |
|
| EE_Third Octave Band LSM (10^-2), SE (10^-2) |
|
| EE_VLHR LSM (10^-2), SE (10^-2) |
|
| MM_Cepstral Peak Prominence LSM (10^-2), SE (10^-2) |
|
| MM_Harmonicity LSM (10^-3), SE (10^-2) |
|
| MM_MFCC mean 01 LSM (10^-1), SE (10^-1) |
|
| MM_MFCC mean 02 LSM (10^-1), SE (10^-1) |
|
| MM_MFCC mean 03 LSM (10^-1), SE (10^-1) |
|
| MM_MFCC mean 04 LSM (10^-1), SE (10^-2) |
|
| MM_MFCC mean 05 LSM (10^-1), SE (10^-2) |
|
| MM_MFCC mean 06 LSM (10^-2), SE (10^-2) |
|
| MM_MFCC mean 07 LSM (10^-1), SE (10^-2) |
|
| MM_MFCC mean 08 LSM (10^-1), SE (10^-2) |
|
| MM_MFCC mean 09 LSM (10^-2), SE (10^-2) |
|
| MM_MFCC mean 10 LSM (10^-2), SE (10^-2) |
|
| MM_MFCC mean 11 LSM (10^-1), SE (10^-2) |
|
| MM_MFCC mean 12 LSM (10^-2), SE (10^-2) |
|
| MM_MFCC mean 13 LSM (10^-2), SE (10^-2) |
|
| MM_MFCC std 01 LSM (10^-2), SE (10^-2) |
|
| MM_MFCC std 02 LSM (10^-2), SE (10^-2) |
|
| MM_MFCC std 03 LSM (10^-3), SE (10^-2) |
|
| MM_MFCC std 04 LSM (10^-3), SE (10^-2) |
|
| MM_MFCC std 05 LSM (10^-2), SE (10^-3) |
|
| MM_MFCC std 06 LSM (10^-2), SE (10^-2) |
|
| MM_MFCC std 07 LSM (10^-3), SE (10^-2) |
|
| MM_MFCC std 08 LSM (10^-2), SE (10^-2) |
|
| MM_MFCC std 09 LSM (10^-2), SE (10^-2) |
|
| MM_MFCC std 10 LSM (10^-3), SE (10^-3) |
|
| MM_MFCC std 11 LSM (10^-2), SE (10^-2) |
|
| MM_MFCC std 12 LSM (10^-2), SE (10^-3) |
|
| MM_MFCC std 13 LSM (10^-3), SE (10^-2) |
|
| MM_SNR LSM (10^-3), SE (10^-2) |
|
| MM_Shimmer Local dB LSM (10^-4), SE (10^-4) |
|
| MM_Spectral Flatness LSM (10^-2), SE (10^-2) |
|
| MM_Third Octave Band LSM (10^-1), SE (10^-2) |
|
| MM_VLHR LSM (10^-3), SE (10^-2) |
|
| READ_MFCC mean 01 LSM (10^-1), SE (10^-1) |
|
| READ_MFCC mean 02 LSM (10^-2), SE (10^-1) |
|
| READ_MFCC mean 03 LSM (10^-1), SE (10^-2) |
|
| READ_MFCC mean 04 LSM (10^-2), SE (10^-2) |
|
| READ_MFCC mean 05 LSM (10^-2), SE (10^-2) |
|
| READ_MFCC mean 06 LSM (10^-1), SE (10^-2) |
|
| READ_MFCC mean 07 LSM (10^-2), SE (10^-2) |
|
| READ_MFCC mean 08 LSM (10^-2), SE (10^-2) |
|
| READ_MFCC mean 09 LSM (10^-2), SE (10^-2) |
|
| READ_MFCC mean 10 LSM (10^-2), SE (10^-2) |
|
| READ_MFCC mean 11 LSM (10^-3), SE (10^-2) |
|
| READ_MFCC mean 12 LSM (10^-2), SE (10^-2) |
|
| READ_MFCC mean 13 LSM (10^-2), SE (10^-2) |
|
| READ_MFCC std 01 LSM (10^-1), SE (10^-2) |
|
| READ_MFCC std 02 LSM (10^-2), SE (10^-2) |
|
| READ_MFCC std 03 LSM (10^-2), SE (10^-2) |
|
| READ_MFCC std 04 LSM (10^-2), SE (10^-2) |
|
| READ_MFCC std 05 LSM (10^-2), SE (10^-2) |
|
| READ_MFCC std 06 LSM (10^-3), SE (10^-2) |
|
| READ_MFCC std 07 LSM (10^-2), SE (10^-3) |
|
| READ_MFCC std 08 LSM (10^-3), SE (10^-3) |
|
| READ_MFCC std 09 LSM (10^-3), SE (10^-3) |
|
| READ_MFCC std 10 LSM (10^-4), SE (10^-3) |
|
| READ_MFCC std 11 LSM (10^-3), SE (10^-3) |
|
| READ_MFCC std 12 LSM (10^-3), SE (10^-3) |
|
| READ_MFCC std 13 LSM (10^-3), SE (10^-3) |
|
| READ_SNR LSM (10^-3), SE (10^-2) |
|
EE_Harmonicity (The statistical data given below have exponential factor in addition to the values mentioned. For dispersion value it was 10^-2). |
| Mixed Models Analysis |
| 0.6605 |
| Slope |
| 0.007667 |
| Standard Error of the Mean |
| 1.741 |
| 2-Sided |
| 90 |
| -0.02119 |
| 0.03653 |
| Other |
| EE_MFCC mean 01 (The statistical data given below have exponential factor in addition to the values mentioned. For dispersion value it was 10^-1). | Mixed Models Analysis | <.0001 | Slope | 1.268 | Standard Error of the Mean | 2.820 | 2-Sided | 90 | 0.8012 | 1.736 | Other |
| EE_MFCC mean 02 (The statistical data given below have exponential factor in addition to the values mentioned. For upper limit, lower limit, estimated value and dispersion value it was 10^-1). | Mixed Models Analysis | 0.4117 | Slope | -1.752 | Standard Error of the Mean | 2.127 | 2-Sided | 90 | -5.276 | 1.773 | Other |
| EE_MFCC mean 03 (The statistical data given below have exponential factor in addition to the values mentioned. For upper limit, estimated value and dispersion value it was 10^-1. For lower limit it was 10^-2). | Mixed Models Analysis | 0.2728 | Slope | 1.390 | Standard Error of the Mean | 1.262 | 2-Sided | 90 | -7.012 | 3.482 | Other |
| EE_MFCC mean 04 (The statistical data given below have exponential factor in addition to the values mentioned. For lower limit, estimated value and dispersion value it was 10^-1. For upper limit it was 10^-2). | Mixed Models Analysis | 0.2411 | Slope | -1.407 | Standard Error of the Mean | 1.194 | 2-Sided | 90 | -3.385 | 5.724 | Other |
| EE_MFCC mean 05 (The statistical data given below have exponential factor in addition to the values mentioned. For dispersion value it was 10^-2). | Mixed Models Analysis | 0.9599 | Slope | -0.004466 | Standard Error of the Mean | 8.869 | 2-Sided | 90 | -0.1514 | 0.1425 | Other |
| EE_MFCC mean 06 (The statistical data given below have exponential factor in addition to the values mentioned. For dispersion value it was 10^-2). | Mixed Models Analysis | 0.0875 | Slope | -0.1572 | Standard Error of the Mean | 9.127 | 2-Sided | 90 | -0.3084 | -0.005942 | Other |
| EE_MFCC mean 07 (The statistical data given below have exponential factor in addition to the values mentioned. For upper limit and estimated value it was 10^-1. For dispersion value it was 10^-2 and for lower limit it was 10^-3). | Mixed Models Analysis | 0.1029 | Slope | 1.248 | Standard Error of the Mean | 7.598 | 2-Sided | 90 | -1.072 | 2.507 | Other |
| EE_MFCC mean 08 (The statistical data given below have exponential factor in addition to the values mentioned. For lower limit and estimated value it was 10^-1. For upper limit and dispersion value it was 10^-2). | Mixed Models Analysis | 0.1468 | Slope | -1.054 | Standard Error of the Mean | 7.218 | 2-Sided | 90 | -2.250 | 1.423 | Other |
| EE_MFCC mean 09 (The statistical data given below have exponential factor in addition to the values mentioned. For dispersion value it was 10^-2). | Mixed Models Analysis | 0.3649 | Slope | 0.05944 | Standard Error of the Mean | 6.536 | 2-Sided | 90 | -0.04887 | 0.1678 | Other |
| EE_MFCC mean 10 (The statistical data given below have exponential factor in addition to the values mentioned. For dispersion value it was 10^-2). | Mixed Models Analysis | 0.6050 | Slope | -0.03115 | Standard Error of the Mean | 6.007 | 2-Sided | 90 | -0.1307 | 0.06839 | Other |
| EE_MFCC mean 11 (The statistical data given below have exponential factor in addition to the values mentioned. For dispersion value it was 10^-2). | Mixed Models Analysis | 0.7483 | Slope | -0.01908 | Standard Error of the Mean | 5.932 | 2-Sided | 90 | -0.1174 | 0.07922 | Other |
| EE_MFCC mean 12 (The statistical data given below have exponential factor in addition to the values mentioned. For upper limit, lower limit and dispersion value it was 10^-2. For estimated value it was 10^-4). | Mixed Models Analysis | 0.9897 | Slope | -6.574 | Standard Error of the Mean | 5.105 | 2-Sided | 90 | -8.526 | 8.394 | Other |
| EE_MFCC mean 13 (The statistical data given below have exponential factor in addition to the values mentioned. For upper limit, lower limit and dispersion value it was 10^-2. For estimated value it was 10^-3). | Mixed Models Analysis | 0.9228 | Slope | 5.026 | Standard Error of the Mean | 5.176 | 2-Sided | 90 | -8.074 | 9.080 | Other |
| EE_MFCC std 01 (The statistical data given below have exponential factor in addition to the values mentioned. For dispersion value it was 10^-2). | Mixed Models Analysis | 0.0043 | Slope | 0.08365 | Standard Error of the Mean | 2.873 | 2-Sided | 90 | 0.03604 | 0.1313 | Other |
| EE_MFCC std 02 (The statistical data given below have exponential factor in addition to the values mentioned. For dispersion value it was 10^-2). | Mixed Models Analysis | 0.0153 | Slope | 0.02906 | Standard Error of the Mean | 1.181 | 2-Sided | 90 | 0.009486 | 0.04863 | Other |
| EE_MFCC std 03 (The statistical data given below have exponential factor in addition to the values mentioned. For upper limit, lower limit, estimated value and dispersion value it was 10^-2). | Mixed Models Analysis | 0.0071 | Slope | 3.960 | Standard Error of the Mean | 1.447 | 2-Sided | 90 | 1.563 | 6.357 | Other |
| EE_MFCC std 04 (The statistical data given below have exponential factor in addition to the values mentioned. For upper limit, lower limit, estimated value and dispersion value it was 10^-2). | Mixed Models Analysis | 0.0070 | Slope | 2.816 | Standard Error of the Mean | 1.026 | 2-Sided | 90 | 1.115 | 4.516 | Other |
| EE_MFCC std 05 (The statistical data given below have exponential factor in addition to the values mentioned. For dispersion value it was 10^-2). | Mixed Models Analysis | 0.4513 | Slope | 0.007814 | Standard Error of the Mean | 1.034 | 2-Sided | 90 | -0.009323 | 0.02495 | Other |
| EE_MFCC std 06 (The statistical data given below have exponential factor in addition to the values mentioned. For upper limit and estimated value it was 10^-2. For lower limit and dispersion value it was 10^-3). | Mixed Models Analysis | 0.1753 | Slope | 1.151 | Standard Error of the Mean | 8.443 | 2-Sided | 90 | -2.483 | 2.550 | Other |
| EE_MFCC std 07 (The statistical data given below have exponential factor in addition to the values mentioned. For upper limit, lower limit and estimated value it was 10^-2. For dispersion it was 10^-3). | Mixed Models Analysis | 0.0026 | Slope | 2.528 | Standard Error of the Mean | 8.228 | 2-Sided | 90 | 1.164 | 3.891 | Other |
| EE_MFCC std 08 (The statistical data given below have exponential factor in addition to the values mentioned. For dispersion value it was 10^-3). | Mixed Models Analysis | 0.0162 | Slope | 0.01755 | Standard Error of the Mean | 7.204 | 2-Sided | 90 | 0.005616 | 0.02949 | Other |
| EE_MFCC std 09 (The statistical data given below have exponential factor in addition to the values mentioned. For upper limit, lower limit and estimated value it was 10^-2. For dispersion value it was 10^-3). | Mixed Models Analysis | <.0001 | Slope | 2.673 | Standard Error of the Mean | 5.892 | 2-Sided | 90 | 1.697 | 3.650 | Other |
| EE_MFCC std 10 (The statistical data given below have exponential factor in addition to the values mentioned. For dispersion value it was 10^-3). | Mixed Models Analysis | 0.0148 | Slope | 0.01394 | Standard Error of the Mean | 5.642 | 2-Sided | 90 | 0.004595 | 0.02329 | Other |
| EE_MFCC std 11 (The statistical data given below have exponential factor in addition to the values mentioned. For dispersion value it was 10^-3). | Mixed Models Analysis | 0.0219 | Slope | 0.01547 | Standard Error of the Mean | 6.666 | 2-Sided | 90 | 0.004425 | 0.02652 | Other |
| EE_MFCC std 12 (The statistical data given below have exponential factor in addition to the values mentioned. For upper limit and estimated value it was 10^-2. For lower limit and dispersion value it was 10^-3). | Mixed Models Analysis | 0.0703 | Slope | 1.118 | Standard Error of the Mean | 6.122 | 2-Sided | 90 | 1.032 | 2.132 | Other |
| EE_MFCC std 13 (The statistical data given below have exponential factor in addition to the values mentioned. For dispersion value it was 10^-3). | Mixed Models Analysis | 0.0282 | Slope | 0.01160 | Standard Error of the Mean | 5.226 | 2-Sided | 90 | 0.002940 | 0.02026 | Other |
| EE_SNR (The statistical data given below have exponential factor in addition to the values mentioned. For dispersion value it was 10^-2). | Mixed Models Analysis | 0.1570 | Slope | 0.04771 | Standard Error of the Mean | 3.351 | 2-Sided | 90 | -0.007823 | 0.1032 | Other |
| EE_Shimmer Local dB (The statistical data given below have exponential factor in addition to the values mentioned. For dispersion value it was 10^-4). | Mixed Models Analysis | 0.4131 | Slope | 0.0008053 | Standard Error of the Mean | 9.807 | 2-Sided | 90 | -0.0008199 | 0.002431 | Other |
| EE_Spectral Flatness (The statistical data given below have exponential factor in addition to the values mentioned. For dispersion value it was 10^-2). | Mixed Models Analysis | 0.0391 | Slope | -0.03945 | Standard Error of the Mean | 1.892 | 2-Sided | 90 | -0.07080 | -0.008096 | Other |
| EE_Third Octave Band (The statistical data given below have exponential factor in addition to the values mentioned. For dispersion value it was 10^-2). | Mixed Models Analysis | 0.4018 | Slope | -0.07075 | Standard Error of the Mean | 8.409 | 2-Sided | 90 | -0.2101 | 0.06860 | Other |
| EE_VLHR (The statistical data given below have exponential factor in addition to the values mentioned. For upper limit, lower limit, estimated value and dispersion value it was 10^-2). | Mixed Models Analysis | 0.6466 | Slope | 1.658 | Standard Error of the Mean | 3.607 | 2-Sided | 90 | -4.319 | 7.635 | Other |
| MM_Cepstral Peak Prominence (The statistical data given below have exponential factor in addition to the values mentioned. For upper limit, lower limit, estimated value and dispersion value it was 10^-2). | Mixed Models Analysis | 0.4118 | Slope | 1.172 | Standard Error of the Mean | 1.423 | 2-Sided | 90 | -1.186 | 3.530 | Other |
| MM_Harmonicity (The statistical data given below have exponential factor in addition to the values mentioned. For upper limit, lower limit and dispersion value it was 10^-2. For estimated value it was 10^-3). | Mixed Models Analysis | 0.9481 | Slope | -1.282 | Standard Error of the Mean | 1.965 | 2-Sided | 90 | -3.385 | 3.129 | Other |
| MM_MFCC mean 01 (The statistical data given below have exponential factor in addition to the values mentioned. For dispersion value it was 10^-1). | Mixed Models Analysis | 0.0007 | Slope | 0.9159 | Standard Error of the Mean | 2.641 | 2-Sided | 90 | 0.4783 | 1.354 | Other |
| MM_MFCC mean 02 (The statistical data given below have exponential factor in addition to the values mentioned. For lower limit, estimated value and dispersion value it was 10^-1. For upper limit it was 10^-2). | Mixed Models Analysis | 0.2519 | Slope | -2.180 | Standard Error of the Mean | 1.894 | 2-Sided | 90 | -5.319 | 9.585 | Other |
| MM_MFCC mean 03 (The statistical data given below have exponential factor in addition to the values mentioned. For upper limit, estimated value and dispersion value it was 10^-1. For lower limit it was 10^-2). | Mixed Models Analysis | 0.0791 | Slope | 1.821 | Standard Error of the Mean | 1.028 | 2-Sided | 90 | 1.166 | 3.524 | Other |
| MM_MFCC mean 04 (The statistical data given below have exponential factor in addition to the values mentioned. For dispersion value it was 10^-2). | Mixed Models Analysis | 0.0163 | Slope | -0.2064 | Standard Error of the Mean | 8.474 | 2-Sided | 90 | -0.3468 | -0.06599 | Other |
| MM_MFCC mean 05 (The statistical data given below have exponential factor in addition to the values mentioned. For upper limit and dispersion value it was 10^-2. For lower limit and estimated value it was 10^-1). | Mixed Models Analysis | 0.1932 | Slope | -1.265 | Standard Error of the Mean | 9.670 | 2-Sided | 90 | -2.867 | 3.375 | Other |
| MM_MFCC mean 06 (The statistical data given below have exponential factor in addition to the values mentioned. For dispersion value it was 10^-2). | Mixed Models Analysis | 0.7752 | Slope | 0.02851 | Standard Error of the Mean | 9.960 | 2-Sided | 90 | -0.1365 | 0.1936 | Other |
| MM_MFCC mean 07 (The statistical data given below have exponential factor in addition to the values mentioned. For upper limit and estimated value it was 10^-1. For lower limit it was 10^-3. For dispersion value it was 10^-2). | Mixed Models Analysis | 0.1126 | Slope | 1.209 | Standard Error of the Mean | 7.569 | 2-Sided | 90 | -4.480 | 2.464 | Other |
| MM_MFCC mean 08 (The statistical data given below have exponential factor in addition to the values mentioned. For dispersion value it was 10^-2). | Mixed Models Analysis | 0.0102 | Slope | -0.2215 | Standard Error of the Mean | 8.498 | 2-Sided | 90 | -0.3624 | -0.08072 | Other |
| MM_MFCC mean 09 (The statistical data given below have exponential factor in addition to the values mentioned. For dispersion value it was 10^-2). | Mixed Models Analysis | 0.4332 | Slope | 0.05560 | Standard Error of the Mean | 7.072 | 2-Sided | 90 | -0.06159 | 0.1728 | Other |
| MM_MFCC mean 10 (The statistical data given below have exponential factor in addition to the values mentioned. For dispersion value it was 10^-2). | Mixed Models Analysis | 0.8448 | Slope | 0.01214 | Standard Error of the Mean | 6.190 | 2-Sided | 90 | -0.09044 | 0.1147 | Other |
| MM_MFCC mean 11 (The statistical data given below have exponential factor in addition to the values mentioned. For dispersion value it was 10^-2). | Mixed Models Analysis | 0.0244 | Slope | -0.1106 | Standard Error of the Mean | 4.852 | 2-Sided | 90 | -0.1910 | -0.03016 | Other |
| MM_MFCC mean 12 (The statistical data given below have exponential factor in addition to the values mentioned. For dispersion value it was 10^-2). | Mixed Models Analysis | 0.3136 | Slope | -0.04884 | Standard Error of the Mean | 4.827 | 2-Sided | 90 | -0.1288 | 0.03115 | Other |
| MM_MFCC mean 13 (The statistical data given below have exponential factor in addition to the values mentioned. For dispersion value it was 10^-2). | Mixed Models Analysis | 0.5240 | Slope | 0.03600 | Standard Error of the Mean | 5.634 | 2-Sided | 90 | -0.05736 | 0.1294 | Other |
| MM_MFCC std 01 (The statistical data given below have exponential factor in addition to the values mentioned. For upper limit, lower limit, estimated value and dispersion value it was 10^-2). | Mixed Models Analysis | 0.3493 | Slope | 2.909 | Standard Error of the Mean | 3.096 | 2-Sided | 90 | -2.222 | 8.039 | Other |
| MM_MFCC std 02 (The statistical data given below have exponential factor in addition to the values mentioned. For upper limit, lower limit, estimated value and dispersion value it was 10^-2). | Mixed Models Analysis | 0.5087 | Slope | 1.720 | Standard Error of the Mean | 2.595 | 2-Sided | 90 | -2.580 | 6.019 | Other |
| MM_MFCC std 03 (The statistical data given below have exponential factor in addition to the values mentioned. For dispersion value it was 10^-2). | Mixed Models Analysis | 0.7701 | Slope | 0.004403 | Standard Error of the Mean | 1.503 | 2-Sided | 90 | -0.02051 | 0.02931 | Other |
| MM_MFCC std 04 (The statistical data given below have exponential factor in addition to the values mentioned. For dispersion value it was 10^-2). | Mixed Models Analysis | 0.6461 | Slope | 0.007542 | Standard Error of the Mean | 1.639 | 2-Sided | 90 | -0.01961 | 0.03470 | Other |
| MM_MFCC std 05 (The statistical data given below have (The statistical data given below have exponential factor in addition to the values mentioned. For upper limit, lower limit and estimated value it was 10^-2. For dispersion value it was 10^-3). | Mixed Models Analysis | 0.0044 | Slope | 2.386 | Standard Error of the Mean | 8.233 | 2-Sided | 90 | 1.022 | 3.750 | Other |
| MM_MFCC std 06 (The statistical data given below have exponential factor in addition to the values mentioned. For upper limit, estimated value and dispersion value it was 10^-2. For lower limit it was 10^-3). | Mixed Models Analysis | 0.2022 | Slope | 1.593 | Standard Error of the Mean | 1.243 | 2-Sided | 90 | -4.663 | 3.652 | Other |
| MM_MFCC std 07 (The statistical data given below have exponential factor in addition to the values mentioned. For dispersion value it was 10^-2). | Mixed Models Analysis | 0.7890 | Slope | 0.002902 | Standard Error of the Mean | 1.082 | 2-Sided | 90 | -0.01503 | 0.02084 | Other |
| MM_MFCC std 08 (The statistical data given below have exponential factor in addition to the values mentioned. For upper limit, estimated value and dispersion value it was 10^-2. For lower limit it was 10^-3). | Mixed Models Analysis | 0.1510 | Slope | 1.615 | Standard Error of the Mean | 1.118 | 2-Sided | 90 | -2.371 | 3.467 | Other |
| MM_MFCC std 09 (The statistical data given below have exponential factor in addition to the values mentioned. For upper limit, estimated value and dispersion value it was 10^-2. For lower limit it was 10^-3). | Mixed Models Analysis | 0.3138 | Slope | 1.116 | Standard Error of the Mean | 1.104 | 2-Sided | 90 | -7.126 | 2.945 | Other |
| MM_MFCC std 10 (The statistical data given below have exponential factor in addition to the values mentioned. For dispersion value it was 10^-3). | Mixed Models Analysis | 0.8223 | Slope | -0.002168 | Standard Error of the Mean | 9.632 | 2-Sided | 90 | -0.01813 | 0.01379 | Other |
| MM_MFCC std 11 (The statistical data given below have exponential factor in addition to the values mentioned. For upper limit, estimated value and dispersion value it was 10^-2. For lower limit it was 10^-3). | Mixed Models Analysis | 0.1997 | Slope | 1.394 | Standard Error of the Mean | 1.081 | 2-Sided | 90 | -3.978 | 3.185 | Other |
| MM_MFCC std 12 (The statistical data given below have exponential factor in addition to the values mentioned. For dispersion value it was 10^-3). | Mixed Models Analysis | 0.0398 | Slope | 0.01375 | Standard Error of the Mean | 6.622 | 2-Sided | 90 | 0.002780 | 0.02473 | Other |
| MM_MFCC std 13 (The statistical data given below have exponential factor in addition to the values mentioned. For dispersion value it was 10^-2). | Mixed Models Analysis | 0.8107 | Slope | -0.002892 | Standard Error of the Mean | 1.205 | 2-Sided | 90 | -0.02286 | 0.01707 | Other |
| MM_SNR (The statistical data given below have exponential factor in addition to the values mentioned. For upper limit, lower limit and dispersion value it was 10^-2. For estimated value it was 10^-3). | Mixed Models Analysis | 0.9242 | Slope | -3.105 | Standard Error of the Mean | 3.256 | 2-Sided | 90 | -5.706 | 5.085 | Other |
| MM_Shimmer Local dB (The statistical data given below have exponential factor in addition to the values mentioned. For dispersion value it was 10^-4). | Mixed Models Analysis | 0.5277 | Slope | 0.0006145 | Standard Error of the Mean | 9.704 | 2-Sided | 90 | -0.0009936 | 0.002223 | Other |
| MM_Spectral Flatness (The statistical data given below have exponential factor in addition to the values mentioned. For lower limit, estimated value and dispersion value it was 10^-2. For upper limit it was 10^-3). | Mixed Models Analysis | 0.1418 | Slope | -2.911 | Standard Error of the Mean | 1.969 | 2-Sided | 90 | -6.174 | 3.522 | Other |
| MM_Third Octave Band (The statistical data given below have exponential factor in addition to the values mentioned. For dispersion value it was 10^-2). | Mixed Models Analysis | 0.0924 | Slope | -0.1487 | Standard Error of the Mean | 8.770 | 2-Sided | 90 | -0.2940 | -0.003375 | Other |
| MM_VLHR (The statistical data given below have exponential factor in addition to the values mentioned. For upper limit, lower limit and dispersion value it was 10^-2. For estimated value it was 10^-3). | Mixed Models Analysis | 0.9277 | Slope | 3.089 | Standard Error of the Mean | 3.396 | 2-Sided | 90 | -5.318 | 5.936 | Other |
| READ_MFCC mean 01 (The statistical data given below have exponential factor in addition to the values mentioned. For dispersion value it was 10^-1). | Mixed Models Analysis | <.0001 | Slope | 0.8362 | Standard Error of the Mean | 2.077 | 2-Sided | 90 | 0.4920 | 1.180 | Other |
| READ_MFCC mean 02 (The statistical data given below have (The statistical data given below have exponential factor in addition to the values mentioned. For dispersion value it was 10^-1). | Mixed Models Analysis | 0.7568 | Slope | 0.03559 | Standard Error of the Mean | 1.147 | 2-Sided | 90 | -0.1545 | 0.2256 | Other |
| READ_MFCC mean 03 (The statistical data given below have exponential factor in addition to the values mentioned. For dispersion value it was 10^-2). | Mixed Models Analysis | 0.0095 | Slope | 0.2043 | Standard Error of the Mean | 7.752 | 2-Sided | 90 | 0.07585 | 0.3328 | Other |
| READ_MFCC mean 04 (The statistical data given below have exponential factor in addition to the values mentioned. For dispersion value it was 10^-2). | Mixed Models Analysis | 0.1991 | Slope | -0.08280 | Standard Error of the Mean | 6.413 | 2-Sided | 90 | -0.1891 | 0.02348 | Other |
| READ_MFCC mean 05 (The statistical data given below have exponential factor in addition to the values mentioned. For dispersion value it was 10^-2). | Mixed Models Analysis | 0.6469 | Slope | -0.02415 | Standard Error of the Mean | 5.260 | 2-Sided | 90 | -0.1113 | 0.06301 | Other |
| READ_MFCC mean 06 (The statistical data given below have exponential factor in addition to the values mentioned. For dispersion value it was 10^-2). | Mixed Models Analysis | 0.0150 | Slope | -0.1209 | Standard Error of the Mean | 4.904 | 2-Sided | 90 | -0.2022 | -0.03967 | Other |
| READ_MFCC mean 07 (The statistical data given below have exponential factor in addition to the values mentioned. For dispersion value it was 10^-2). | Mixed Models Analysis | 0.5736 | Slope | 0.02617 | Standard Error of the Mean | 4.639 | 2-Sided | 90 | -0.05070 | 0.1030 | Other |
| READ_MFCC mean 08 (The statistical data given below have exponential factor in addition to the values mentioned. For dispersion value it was 10^-2). | Mixed Models Analysis | 0.0894 | Slope | -0.07305 | Standard Error of the Mean | 4.267 | 2-Sided | 90 | -0.1438 | -0.002335 | Other |
| READ_MFCC mean 09 (The statistical data given below have exponential factor in addition to the values mentioned. For upper limit, lower limit, estimated value and dispersion value it was 10^-2). | Mixed Models Analysis | 0.5936 | Slope | -2.369 | Standard Error of the Mean | 4.428 | 2-Sided | 90 | -9.706 | 4.968 | Other |
| READ_MFCC mean 10 (The statistical data given below have exponential factor in addition to the values mentioned. For dispersion value it was 10^-2). | Mixed Models Analysis | 0.0290 | Slope | -0.07377 | Standard Error of the Mean | 3.339 | 2-Sided | 90 | -0.1291 | -0.01844 | Other |
| READ_MFCC mean 11 (The statistical data given below have exponential factor in addition to the values mentioned. For dispersion value it was 10^-2). | Mixed Models Analysis | 0.8127 | Slope | 0.008703 | Standard Error of the Mean | 3.665 | 2-Sided | 90 | -0.05203 | 0.06944 | Other |
| READ_MFCC mean 12 (The statistical data given below have exponential factor in addition to the values mentioned. For dispersion value it was 10^-2). | Mixed Models Analysis | 0.0262 | Slope | -0.07414 | Standard Error of the Mean | 3.294 | 2-Sided | 90 | -0.1287 | -0.01955 | Other |
| READ_MFCC mean 13 (The statistical data given below have exponential factor in addition to the values mentioned. For upper limit, lower limit, estimated value and dispersion value it was 10^-2). | Mixed Models Analysis | 0.2809 | Slope | 2.929 | Standard Error of the Mean | 2.705 | 2-Sided | 90 | -1.553 | 7.412 | Other |
| READ_MFCC std 01 (The statistical data given below have exponential factor in addition to the values mentioned. For upper limit, lower limit and estimated value it was 10^-1. For dispersion value it was 10^-2). | Mixed Models Analysis | <.0001 | Slope | -2.717 | Standard Error of the Mean | 6.612 | 2-Sided | 90 | -3.812 | -1.621 | Other |
| READ_MFCC std 02 (The statistical data given below have exponential factor in addition to the values mentioned. For dispersion value it was 10^-2). | Mixed Models Analysis | 0.0524 | Slope | -0.05798 | Standard Error of the Mean | 2.961 | 2-Sided | 90 | -0.1070 | -0.008915 | Other |
| READ_MFCC std 03 (The statistical data given below have exponential factor in addition to the values mentioned. For upper limit, lower limit, estimated value and dispersion value it was 10^-2). | Mixed Models Analysis | 0.5716 | Slope | -1.008 | Standard Error of the Mean | 1.778 | 2-Sided | 90 | -3.955 | 1.938 | Other |
| READ_MFCC std 04 (The statistical data given below have exponential factor in addition to the values mentioned. For dispersion value it was 10^-2). | Mixed Models Analysis | 0.0640 | Slope | -0.02230 | Standard Error of the Mean | 1.193 | 2-Sided | 90 | -0.04208 | -0.002526 | Other |
| READ_MFCC std 05 (The statistical data given below have exponential factor in addition to the values mentioned. For lower limit, estimated value and dispersion value it was 10^-2. For upper limit it was 10^-3). | Mixed Models Analysis | 0.2584 | Slope | -1.336 | Standard Error of the Mean | 1.176 | 2-Sided | 90 | -3.285 | 6.138 | Other |
| READ_MFCC std 06 (The statistical data given below have exponential factor in addition to the values mentioned. For dispersion value it was 10^-2). | Mixed Models Analysis | 0.6465 | Slope | -0.006497 | Standard Error of the Mean | 1.413 | 2-Sided | 90 | -0.02992 | 0.01692 | Other |
| READ_MFCC std 07 (The statistical data given below have exponential factor in addition to the values mentioned. For lower limit and estimated value it was 10^-2. For dispersion value it was 10^-3 and for upper limit it was 10^-4). | Mixed Models Analysis | 0.1177 | Slope | -1.213 | Standard Error of the Mean | 7.700 | 2-Sided | 90 | -2.489 | 6.297 | Other |
| READ_MFCC std 08 (The statistical data given below have exponential factor in addition to the values mentioned. For dispersion value it was 10^-3). | Mixed Models Analysis | 0.4155 | Slope | -0.007959 | Standard Error of the Mean | 9.743 | 2-Sided | 90 | -0.02411 | 0.008187 | Other |
| READ_MFCC std 09 (The statistical data given below have exponential factor in addition to the values mentioned. For dispersion value it was 10^-3). | Mixed Models Analysis | 0.6067 | Slope | -0.004137 | Standard Error of the Mean | 8.017 | 2-Sided | 90 | -0.01742 | 0.009148 | Other |
| READ_MFCC std 10 (The statistical data given below have exponential factor in addition to the values mentioned. For dispersion value it was 10^-3). | Mixed Models Analysis | 0.9603 | Slope | 0.0003760 | Standard Error of the Mean | 7.531 | 2-Sided | 90 | -0.01210 | 0.01286 | Other |
| READ_MFCC std 11 (The statistical data given below have exponential factor in addition to the values mentioned. For dispersion value it was 10^-3). | Mixed Models Analysis | 0.7022 | Slope | -0.002185 | Standard Error of the Mean | 5.703 | 2-Sided | 90 | -0.01164 | 0.007265 | Other |
| READ_MFCC std 12 (The statistical data given below have exponential factor in addition to the values mentioned. For dispersion value it was 10^-3). | Mixed Models Analysis | 0.1818 | Slope | 0.007716 | Standard Error of the Mean | 5.746 | 2-Sided | 90 | -0.001806 | 0.01724 | Other |
| READ_MFCC std 13 (The statistical data given below have exponential factor in addition to the values mentioned. For dispersion value it was 10^-3). | Mixed Models Analysis | 0.5324 | Slope | -0.004019 | Standard Error of the Mean | 6.419 | 2-Sided | 90 | -0.01466 | 0.006618 | Other |
| READ_SNR (The statistical data given below have exponential factor in addition to the values mentioned. For dispersion value it was 10^-2). | Mixed Models Analysis | 0.8524 | Slope | 0.005103 | Standard Error of the Mean | 2.737 | 2-Sided | 90 | -0.04025 | 0.05046 | Other |
|
| EE_MFCC 1st order delta 03 LSM (10^-3), SE (10^-3) |
|
| EE_MFCC 1st order delta 04 LSM (10^-3), SE (10^-4) |
|
| EE_MFCC 1st order delta 05 LSM (10^-3), SE (10^-4) |
|
| EE_MFCC 1st order delta 06 LSM (10^-4), SE (10^-4) |
|
| EE_MFCC 1st order delta 07 LSM (10^-4), SE (10^-4) |
|
| EE_MFCC 1st order delta 08 LSM (10^-4), SE (10^-4) |
|
| EE_MFCC 1st order delta 09 LSM (10^-3), SE (10^-4) |
|
| EE_MFCC 1st order delta 10 LSM (10^-4), SE (10^-4) |
|
| EE_MFCC 1st order delta 11 LSM (10^-4), SE (10^-4) |
|
| EE_MFCC 1st order delta 12 LSM (10^-4), SE (10^-4) |
|
| EE_MFCC 1st order delta 13 LSM (10^-4), SE (10^-4) |
|
| EE_MFCC 2nd order delta 01 LSM (10^-4), SE (10^-3) |
|
| EE_MFCC 2nd order delta 02 LSM (10^-3), SE (10^-4) |
|
| EE_MFCC 2nd order delta 03 LSM (10^-4), SE (10^-4) |
|
| EE_MFCC 2nd order delta 04 LSM (10^-5), SE (10^-4) |
|
| EE_MFCC 2nd order delta 05 LSM (10^-4), SE (10^-4) |
|
| EE_MFCC 2nd order delta 06 LSM (10^-4), SE (10^-4) |
|
| EE_MFCC 2nd order delta 07 LSM (10^-5), SE (10^-4) |
|
| EE_MFCC 2nd order delta 08 LSM (10^-4), SE (10^-4) |
|
| EE_MFCC 2nd order delta 09 LSM (10^-4), SE (10^-4) |
|
| EE_MFCC 2nd order delta 10 LSM (10^-4), SE (10^-4) |
|
| EE_MFCC 2nd order delta 11 LSM (10^-5), SE (10^-4) |
|
| EE_MFCC 2nd order delta 12 LSM (10^-4), SE (10^-4) |
|
| EE_MFCC 2nd order delta 13 LSM (10^-4), SE (10^-4) |
|
| MM_Coefficient of Variation F0 LSM (10^-4), SE (10^-4) |
|
| MM_MFCC 1st order delta 01 LSM (10^-5), SE (10^-3) |
|
| MM_MFCC 1st order delta 02 LSM (10^-4), SE (10^-3) |
|
| MM_MFCC 1st order delta 03 LSM (10^-3), SE (10^-3) |
|
| MM_MFCC 1st order delta 04 LSM (10^-4), SE (10^-3) |
|
| MM_MFCC 1st order delta 05 LSM (10^-3), SE (10^-4) |
|
| MM_MFCC 1st order delta 06 LSM (10^-4), SE (10^-3) |
|
| MM_MFCC 1st order delta 07 LSM (10^-4), SE (10^-4) |
|
| MM_MFCC 1st order delta 08 LSM (10^-3), SE (10^-4) |
|
| MM_MFCC 1st order delta 09 LSM (10^-4), SE (10^-4) |
|
| MM_MFCC 1st order delta 10 LSM (10^-3), SE (10^-4) |
|
| MM_MFCC 1st order delta 11 LSM (10^-4), SE (10^-4) |
|
| MM_MFCC 1st order delta 12 LSM (10^-4), SE (10^-4) |
|
| MM_MFCC 1st order delta 13 LSM (10^-4), SE (10^-4) |
|
| MM_MFCC 2nd order delta 01 LSM (10^-3), SE (10^-3) |
|
| MM_MFCC 2nd order delta 02 LSM (10^-4), SE (10^-4) |
|
| MM_MFCC 2nd order delta 03 LSM (10^-3), SE (10^-4) |
|
| MM_MFCC 2nd order delta 04 LSM (10^-3), SE (10^-4) |
|
| MM_MFCC 2nd order delta 05 LSM (10^-3), SE (10^-4) |
|
| MM_MFCC 2nd order delta 06 LSM (10^-4), SE (10^-4) |
|
| MM_MFCC 2nd order delta 07 LSM (10^-4), SE (10^-4) |
|
| MM_MFCC 2nd order delta 08 LSM (10^-3), SE (10^-4) |
|
| MM_MFCC 2nd order delta 09 LSM (10^-4), SE (10^-4) |
|
| MM_MFCC 2nd order delta 10 LSM (10^-4), SE (10^-4) |
|
| MM_MFCC 2nd order delta 11 LSM (10^-4), SE (10^-4) |
|
| MM_MFCC 2nd order delta 12 LSM (10^-4), SE (10^-4) |
|
| MM_MFCC 2nd order delta 13 LSM (10^-4), SE (10^-4) |
|
| READ_MFCC 1st order delta 01 LSM (10^-3), SE (10^-4) |
|
| READ_MFCC 1st order delta 02 LSM (10^-4), SE (10^-4) |
|
| READ_MFCC 1st order delta 03 LSM (10^-4), SE (10^-4) |
|
| READ_MFCC 1st order delta 04 LSM (10^-5), SE (10^-4) |
|
| READ_MFCC 1st order delta 05 LSM (10^-4), SE (10^-4) |
|
| READ_MFCC 1st order delta 06 LSM (10^-4), SE (10^-4) |
|
| READ_MFCC 1st order delta 07 LSM (10^-4), SE (10^-4) |
|
| READ_MFCC 1st order delta 08 LSM (10^-4), SE (10^-4) |
|
| READ_MFCC 1st order delta 09 LSM (10^-5), SE (10^-4) |
|
| READ_MFCC 1st order delta 10 LSM (10^-4), SE (10^-4) |
|
| READ_MFCC 1st order delta 11 LSM (10^-4), SE (10^-5) |
|
| READ_MFCC 1st order delta 12 LSM (10^-4), SE (10^-5) |
|
| READ_MFCC 1st order delta 13 LSM (10^-4), SE (10^-4) |
|
| READ_MFCC 2nd order delta 01 LSM (10^-3), SE (10^-4) |
|
| READ_MFCC 2nd order delta 02 LSM (10^-4), SE (10^-4) |
|
| READ_MFCC 2nd order delta 03 LSM (10^-4), SE (10^-4) |
|
| READ_MFCC 2nd order delta 04 LSM (10^-5), SE (10^-4) |
|
| READ_MFCC 2nd order delta 05 LSM (10^-4), SE (10^-4) |
|
| READ_MFCC 2nd order delta 06 LSM (10^-4), SE (10^-4) |
|
| READ_MFCC 2nd order delta 07 LSM (10^-4), SE (10^-4) |
|
| READ_MFCC 2nd order delta 08 LSM (10^-4), SE (10^-5) |
|
| READ_MFCC 2nd order delta 09 LSM (10^-4), SE (10^-4) |
|
| READ_MFCC 2nd order delta 10 LSM (10^-5), SE (10^-5) |
|
| READ_MFCC 2nd order delta 11 LSM (10^-5), SE (10^-5) |
|
| READ_MFCC 2nd order delta 12 LSM (10^-5), SE (10^-5) |
|
| READ_MFCC 2nd order delta 13 LSM (10^-4), SE (10^-5) |
|
EE_MFCC 1st order delta 01 (The statistical data given below have exponential factor in addition to the values mentioned. For dispersion value it was 10^-3.
| Mixed Models Analysis |
| 0.0438 |
| Slope |
| -0.005601 |
| Standard Error of the Mean |
| 2.751 |
| 2-Sided |
| 90 |
| -0.01016 |
| -0.001043 |
| Other |
| EE_MFCC 1st order delta 02 (The statistical data given below have exponential factor in addition to the values mentioned. For upper limit, lower limit, estimated value and dispersion value it was 10^-3. | Mixed Models Analysis | 0.0057 | Slope | 4.120 | Standard Error of the Mean | 1.464 | 2-Sided | 90 | 1.694 | 6.546 | Other |
| EE_MFCC 1st order delta 03 (The statistical data given below have exponential factor in addition to the values mentioned. For upper limit, lower limit, estimated value and dispersion value it was 10^-3. | Mixed Models Analysis | 0.0042 | Slope | -3.067 | Standard Error of the Mean | 1.053 | 2-Sided | 90 | -4.811 | -1.323 | Other |
| EE_MFCC 1st order delta 04 (The statistical data given below have exponential factor in addition to the values mentioned. For upper limit, lower limit and estimated value it was 10^-3. For dispersion value it was 10^-4). | Mixed Models Analysis | 0.0051 | Slope | 2.780 | Standard Error of the Mean | 9.751 | 2-Sided | 90 | 1.164 | 4.396 | Other |
| EE_MFCC 1st order delta 05 (The statistical data given below have exponential factor in addition to the values mentioned. For lower limit and estimated value it was 10^-3. For upper limit it was 10^-5 and for dispersion value it was 10^-4). | Mixed Models Analysis | 0.1128 | Slope | -1.324 | Standard Error of the Mean | 8.289 | 2-Sided | 90 | -2.698 | 4.973 | Other |
| EE_MFCC 1st order delta 06 (The statistical data given below have exponential factor in addition to the values mentioned. For dispersion value it was 10^-4). | Mixed Models Analysis | 0.7888 | Slope | -0.0002606 | Standard Error of the Mean | 9.707 | 2-Sided | 90 | -0.001869 | 0.001348 | Other |
| EE_MFCC 1st order delta 07 (The statistical data given below have exponential factor in addition to the values mentioned. For dispersion value it was 10^-4). | Mixed Models Analysis | 0.5055 | Slope | -0.0005071 | Standard Error of the Mean | 7.593 | 2-Sided | 90 | -0.001765 | 0.0007512 | Other |
| EE_MFCC 1st order delta 08 (The statistical data given below have exponential factor in addition to the values mentioned. For dispersion value it was 10^-4). | Mixed Models Analysis | 0.6257 | Slope | 0.0003067 | Standard Error of the Mean | 6.273 | 2-Sided | 90 | -0.0007328 | 0.001346 | Other |
| EE_MFCC 1st order delta 09 (The statistical data given below have exponential factor in addition to the values mentioned. For dispersion value it was 10^-4). | Mixed Models Analysis | 0.0413 | Slope | -0.001649 | Standard Error of the Mean | 7.998 | 2-Sided | 90 | -0.002974 | -0.0003238 | Other |
| EE_MFCC 1st order delta 10 (The statistical data given below have exponential factor in addition to the values mentioned. For dispersion value it was 10^-4). | Mixed Models Analysis | 0.2451 | Slope | 0.0008236 | Standard Error of the Mean | 7.053 | 2-Sided | 90 | -0.0003452 | 0.001992 | Other |
| EE_MFCC 1st order delta 11 (The statistical data given below have exponential factor in addition to the values mentioned. For dispersion value it was 10^-4). | Mixed Models Analysis | 0.6702 | Slope | -0.0002920 | Standard Error of the Mean | 6.839 | 2-Sided | 90 | -0.001425 | 0.0008413 | Other |
| EE_MFCC 1st order delta 12 (The statistical data given below have exponential factor in addition to the values mentioned. For dispersion value it was 10^-4). | Mixed Models Analysis | 0.5951 | Slope | -0.0003363 | Standard Error of the Mean | 6.312 | 2-Sided | 90 | -0.001382 | 0.0007097 | Other |
| EE_MFCC 1st order delta 13 (The statistical data given below have exponential factor in addition to the values mentioned. For dispersion value it was 10^-4). | Mixed Models Analysis | 0.2020 | Slope | 0.0007281 | Standard Error of the Mean | 5.677 | 2-Sided | 90 | -0.0002126 | 0.001669 | Other |
| EE_MFCC 2nd order delta 01 (The statistical data given below have exponential factor in addition to the values mentioned. For dispersion value it was 10^-3). | Mixed Models Analysis | 0.7356 | Slope | 0.0005153 | Standard Error of the Mean | 1.523 | 2-Sided | 90 | -0.002008 | 0.003038 | Other |
| EE_MFCC 2nd order delta 02 (The statistical data given below have exponential factor in addition to the values mentioned. For dispersion value it was 10^-4). | Mixed Models Analysis | 0.0522 | Slope | -0.001330 | Standard Error of the Mean | 6.782 | 2-Sided | 90 | -0.002453 | -0.0002057 | Other |
| EE_MFCC 2nd order delta 03 (The statistical data given below have exponential factor in addition to the values mentioned. For dispersion value it was 10^-4). | Mixed Models Analysis | 0.8180 | Slope | -0.0001560 | Standard Error of the Mean | 6.763 | 2-Sided | 90 | -0.001277 | 0.0009647 | Other |
| EE_MFCC 2nd order delta 04 (The statistical data given below have exponential factor in addition to the values mentioned. For dispersion value it was 10^-4. | Mixed Models Analysis | 0.8754 | Slope | -0.0000971 | Standard Error of the Mean | 6.180 | 2-Sided | 90 | -0.001121 | 0.0009270 | Other |
| EE_MFCC 2nd order delta 05 (The statistical data given below have exponential factor in addition to the values mentioned. For dispersion value it was 10^-4). | Mixed Models Analysis | 0.4192 | Slope | 0.0004520 | Standard Error of the Mean | 5.576 | 2-Sided | 90 | -0.0004721 | 0.001376 | Other |
| EE_MFCC 2nd order delta 06 (The statistical data given below have exponential factor in addition to the values mentioned. For dispersion value it was 10^-4). | Mixed Models Analysis | 0.7849 | Slope | -0.0001528 | Standard Error of the Mean | 5.586 | 2-Sided | 90 | -0.001079 | 0.0007729 | Other |
| EE_MFCC 2nd order delta 07 (The statistical data given below have exponential factor in addition to the values mentioned. For upper limit, lower limit and dispersion value it was 10^-4. For estimated value it was 10^-5). | Mixed Models Analysis | 0.9010 | Slope | -5.254 | Standard Error of the Mean | 4.217 | 2-Sided | 90 | -7.513 | 6.463 | Other |
| EE_MFCC 2nd order delta 08 (The statistical data given below have exponential factor in addition to the values mentioned. For dispersion value it was 10^-4). | Mixed Models Analysis | 0.2329 | Slope | -0.0004591 | Standard Error of the Mean | 3.830 | 2-Sided | 90 | -0.001094 | 0.0001755 | Other |
| EE_MFCC 2nd order delta 09 (The statistical data given below have exponential factor in addition to the values mentioned. For dispersion value it was 10^-4). | Mixed Models Analysis | 0.0583 | Slope | 0.0007046 | Standard Error of the Mean | 3.687 | 2-Sided | 90 | 0.00009366 | 0.001315 | Other |
| EE_MFCC 2nd order delta 10 (The statistical data given below have exponential factor in addition to the values mentioned. For upper limit, lower limit, estimated value and dispersion value it was 10^-4). | Mixed Models Analysis | 0.6654 | Slope | -1.564 | Standard Error of the Mean | 3.606 | 2-Sided | 90 | -7.540 | 4.413 | Other |
| EE_MFCC 2nd order delta 11 (The statistical data given below have exponential factor in addition to the values mentioned. For dispersion value it was 10^-4). | Mixed Models Analysis | 0.8154 | Slope | 0.00006573 | Standard Error of the Mean | 2.810 | 2-Sided | 90 | -0.0003998 | 0.0005313 | Other |
| EE_MFCC 2nd order delta 12 (The statistical data given below have exponential factor in addition to the values mentioned. For dispersion value it was 10^-4). | Mixed Models Analysis | 0.2687 | Slope | -0.0004071 | Standard Error of the Mean | 3.664 | 2-Sided | 90 | -0.001014 | 0.0002001 | Other |
| EE_MFCC 2nd order delta 13 (The statistical data given below have exponential factor in addition to the values mentioned. For upper limit, lower limit, estimated value and dispersion value it was 10^-4). | Mixed Models Analysis | 0.4005 | Slope | 2.799 | Standard Error of the Mean | 3.317 | 2-Sided | 90 | -2.698 | 8.296 | Other |
| MM_Coefficient of Variation F0 (The statistical data given below have exponential factor in addition to the values mentioned. For upper limit, lower limit, estimated value and dispersion value it was 10^-4). | Mixed Models Analysis | 0.5040 | Slope | 1.123 | Standard Error of the Mean | 1.676 | 2-Sided | 90 | -1.654 | 3.901 | Other |
| MM_MFCC 1st order delta 01 (The statistical data given below have exponential factor in addition to the values mentioned. For dispersion value it was 10^-3). | Mixed Models Analysis | 0.9790 | Slope | 0.00007586 | Standard Error of the Mean | 2.882 | 2-Sided | 90 | -0.004701 | 0.004852 | Other |
| MM_MFCC 1st order delta 02 (The statistical data given below have exponential factor in addition to the values mentioned. For dispersion value it was 10^-3). | Mixed Models Analysis | 0.6503 | Slope | 0.0008249 | Standard Error of the Mean | 1.815 | 2-Sided | 90 | -0.002183 | 0.003833 | Other |
| MM_MFCC 1st order delta 03 (The statistical data given below have exponential factor in addition to the values mentioned. For upper limit, lower limit, estimated value and dispersion value it was 10^-3). | Mixed Models Analysis | 0.3705 | Slope | -1.188 | Standard Error of the Mean | 1.322 | 2-Sided | 90 | -3.379 | 1.003 | Other |
| MM_MFCC 1st order delta 04 (The statistical data given below have exponential factor in addition to the values mentioned. For dispersion value it was 10^-3). | Mixed Models Analysis | 0.5111 | Slope | -0.0007258 | Standard Error of the Mean | 1.101 | 2-Sided | 90 | -0.002551 | 0.001099 | Other |
| MM_MFCC 1st order delta 05 (The statistical data given below have exponential factor in addition to the values mentioned. For dispersion value it was 10^-4). | Mixed Models Analysis | 0.0816 | Slope | -0.001326 | Standard Error of the Mean | 7.555 | 2-Sided | 90 | -0.002578 | -0.0000744 | Other |
| MM_MFCC 1st order delta 06 (The statistical data given below have exponential factor in addition to the values mentioned. For dispersion value it was 10^-3). | Mixed Models Analysis | 0.6034 | Slope | 0.0005502 | Standard Error of the Mean | 1.056 | 2-Sided | 90 | -0.001200 | 0.002301 | Other |
| MM_MFCC 1st order delta 07 (The statistical data given below have exponential factor in addition to the values mentioned. For dispersion value it was 10^-4). | Mixed Models Analysis | 0.5220 | Slope | -0.0004691 | Standard Error of the Mean | 7.305 | 2-Sided | 90 | -0.001680 | 0.0007415 | Other |
| MM_MFCC 1st order delta 08 (The statistical data given below have exponential factor in addition to the values mentioned. For dispersion value it was 10^-4). | Mixed Models Analysis | 0.0526 | Slope | -0.001530 | Standard Error of the Mean | 7.820 | 2-Sided | 90 | -0.002826 | -0.0002344 | Other |
| MM_MFCC 1st order delta 09 (The statistical data given below have exponential factor in addition to the values mentioned. For dispersion value it was 10^-4). | Mixed Models Analysis | 0.5689 | Slope | 0.0004166 | Standard Error of the Mean | 7.294 | 2-Sided | 90 | -0.0007920 | 0.001625 | Other |
| MM_MFCC 1st order delta 10 (The statistical data given below have exponential factor in addition to the values mentioned. For dispersion value it was 10^-4). | Mixed Models Analysis | 0.0045 | Slope | -0.002112 | Standard Error of the Mean | 7.299 | 2-Sided | 90 | -0.003321 | -0.0009020 | Other |
| MM_MFCC 1st order delta 11 (The statistical data given below have exponential factor in addition to the values mentioned. For dispersion value it was 10^-4). | Mixed Models Analysis | 0.3058 | Slope | -0.0007706 | Standard Error of the Mean | 7.494 | 2-Sided | 90 | -0.002013 | 0.0004713 | Other |
| MM_MFCC 1st order delta 12 (The statistical data given below have exponential factor in addition to the values mentioned. For dispersion value it was 10^-4). | Mixed Models Analysis | 0.7137 | Slope | 0.0002388 | Standard Error of the Mean | 6.494 | 2-Sided | 90 | -0.0008374 | 0.001315 | Other |
| MM_MFCC 1st order delta 13 (The statistical data given below have exponential factor in addition to the values mentioned. For dispersion value it was 10^-4). | Mixed Models Analysis | 0.7583 | Slope | 0.0002121 | Standard Error of the Mean | 6.877 | 2-Sided | 90 | -0.0009275 | 0.001352 | Other |
| MM_MFCC 2nd order delta 01 (The statistical data given below have exponential factor in addition to the values mentioned. For upper limit it was 10^-5. For lower limit, estimated value and dispersion value it was 10^-3). | Mixed Models Analysis | 0.0974 | Slope | -2.784 | Standard Error of the Mean | 1.667 | 2-Sided | 90 | -5.547 | -2.155 | Other |
| MM_MFCC 2nd order delta 02 (The statistical data given below have exponential factor in addition to the values mentioned. For upper limit and lower limit it was 10^-3. For estimated value and dispersion value it was 10^-4). | Mixed Models Analysis | 0.8810 | Slope | -1.368 | Standard Error of the Mean | 9.117 | 2-Sided | 90 | -1.648 | 1.374 | Other |
| MM_MFCC 2nd order delta 03 (The statistical data given below have exponential factor in addition to the values mentioned. For dispersion value it was 10^-4). | Mixed Models Analysis | 0.0151 | Slope | -0.001551 | Standard Error of the Mean | 6.294 | 2-Sided | 90 | -0.002594 | -0.0005077 | Other |
| MM_MFCC 2nd order delta 04 (The statistical data given below have exponential factor in addition to the values mentioned. For dispersion value it was 10^-4). | Mixed Models Analysis | 0.0135 | Slope | 0.001840 | Standard Error of the Mean | 7.343 | 2-Sided | 90 | 0.0006233 | 0.003057 | Other |
| MM_MFCC 2nd order delta 05 (The statistical data given below have exponential factor in addition to the values mentioned. For dispersion value it was 10^-4). | Mixed Models Analysis | 0.0115 | Slope | 0.001290 | Standard Error of the Mean | 5.029 | 2-Sided | 90 | 0.0004563 | 0.002123 | Other |
| MM_MFCC 2nd order delta 06 (The statistical data given below have exponential factor in addition to the values mentioned. For dispersion value it was 10^-4). | Mixed Models Analysis | 0.8029 | Slope | -0.0001473 | Standard Error of the Mean | 5.891 | 2-Sided | 90 | -0.001123 | 0.0008288 | Other |
| MM_MFCC 2nd order delta 07 (The statistical data given below have exponential factor in addition to the values mentioned. For dispersion value it was 10^-4). | Mixed Models Analysis | 0.2342 | Slope | -0.0005556 | Standard Error of the Mean | 4.647 | 2-Sided | 90 | -0.001326 | 0.0002146 | Other |
| MM_MFCC 2nd order delta 08 (The statistical data given below have exponential factor in addition to the values mentioned. For dispersion value it was 10^-4). | Mixed Models Analysis | 0.0366 | Slope | 0.001128 | Standard Error of the Mean | 5.339 | 2-Sided | 90 | 0.0002436 | 0.002013 | Other |
| MM_MFCC 2nd order delta 09 (The statistical data given below have exponential factor in addition to the values mentioned. For dispersion value it was 10^-4). | Mixed Models Analysis | 0.5220 | Slope | -0.0003297 | Standard Error of the Mean | 5.134 | 2-Sided | 90 | -0.001180 | 0.0005212 | Other |
| MM_MFCC 2nd order delta 10 (The statistical data given below have exponential factor in addition to the values mentioned. For upper limit, lower limit, estimated value and dispersion value it was 10^-4). | Mixed Models Analysis | 0.5520 | Slope | -2.104 | Standard Error of the Mean | 3.528 | 2-Sided | 90 | -7.950 | 3.742 | Other |
| MM_MFCC 2nd order delta 11 (The statistical data given below have exponential factor in addition to the values mentioned. For ldispersion value it was 10^-4). | Mixed Models Analysis | 0.2343 | Slope | 0.0005126 | Standard Error of the Mean | 4.289 | 2-Sided | 90 | -0.0001981 | 0.001223 | Other |
| MM_MFCC 2nd order delta 12 (The statistical data given below have exponential factor in addition to the values mentioned. For upper limit, lower limit, estimated value and dispersion value it was 10^-4). | Mixed Models Analysis | 0.5103 | Slope | 2.703 | Standard Error of the Mean | 4.094 | 2-Sided | 90 | -4.081 | 9.487 | Other |
| MM_MFCC 2nd order delta 13 (The statistical data given below have exponential factor in addition to the values mentioned. For dispersion value it was 10^-4). | Mixed Models Analysis | 0.7056 | Slope | -0.0002020 | Standard Error of the Mean | 5.334 | 2-Sided | 90 | -0.001086 | 0.0006819 | Other |
| READ_MFCC 1st order delta 01 (The statistical data given below have exponential factor in addition to the values mentioned. For upper limit, lower limit and dispersion value it was 10^-3. For estimated value it was 10^-4). | Mixed Models Analysis | 0.0046 | Slope | -2.660 | Standard Error of the Mean | 9.220 | 2-Sided | 90 | -4.188 | -1.132 | Other |
| READ_MFCC 1st order delta 02 (The statistical data given below have exponential factor in addition to the values mentioned. For dispersion value it was 10^-4). | Mixed Models Analysis | 0.1471 | Slope | 0.0006490 | Standard Error of the Mean | 4.448 | 2-Sided | 90 | -0.0000881 | 0.001386 | Other |
| READ_MFCC 1st order delta 03 (The statistical data given below have exponential factor in addition to the values mentioned. For upper limit, lower limit, estimated value and dispersion value it was 10^-4). | Mixed Models Analysis | 0.6842 | Slope | 1.355 | Standard Error of the Mean | 3.323 | 2-Sided | 90 | -4.152 | 6.862 | Other |
| READ_MFCC 1st order delta 04 (The statistical data given below have exponential factor in addition to the values mentioned. For dispersion value it was 10^-4). | Mixed Models Analysis | 0.7664 | Slope | 0.00007664 | Standard Error of the Mean | 2.574 | 2-Sided | 90 | -0.0003499 | 0.0005032 | Other |
| READ_MFCC 1st order delta 05 (The statistical data given below have exponential factor in addition to the values mentioned. For upper limit, lower limit, estimated value and dispersion value it was 10^-4). | Mixed Models Analysis | 0.4015 | Slope | -1.708 | Standard Error of the Mean | 2.028 | 2-Sided | 90 | -5.069 | 1.654 | Other |
| READ_MFCC 1st order delta 06 (The statistical data given below have exponential factor in addition to the values mentioned. For upper limit, estimated value and dispersion value it was 10^-4. For lower limit it was 10^-5). | Mixed Models Analysis | 0.1897 | Slope | 2.510 | Standard Error of the Mean | 1.904 | 2-Sided | 90 | -6.446 | 5.665 | Other |
| READ_MFCC 1st order delta 07 (The statistical data given below have exponential factor in addition to the values mentioned. For upper limit, estimated value and dispersion value it was 10^-4. For lower limit it was 10^-5). | Mixed Models Analysis | 0.1439 | Slope | 2.393 | Standard Error of the Mean | 1.627 | 2-Sided | 90 | -3.035 | 5.090 | Other |
| READ_MFCC 1st order delta 08 (The statistical data given below have exponential factor in addition to the values mentioned. For upper limit, lower limit, estimated value and dispersion value it was 10^-4). | Mixed Models Analysis | 0.0092 | Slope | 4.111 | Standard Error of the Mean | 1.553 | 2-Sided | 90 | 1.537 | 6.685 | Other |
| READ_MFCC 1st order delta 09 (The statistical data given below have exponential factor in addition to the values mentioned. For dispersion value it was 10^-4). | Mixed Models Analysis | 0.7150 | Slope | -0.0000415 | Standard Error of the Mean | 1.134 | 2-Sided | 90 | -0.0002294 | 0.0001464 | Other |
| READ_MFCC 1st order delta 10 (The statistical data given below have exponential factor in addition to the values mentioned. For upper limit, estimated value and dispersion value it was 10^-4. For lower limit it was 10^-5). | Mixed Models Analysis | 0.2194 | Slope | 1.593 | Standard Error of the Mean | 1.291 | 2-Sided | 90 | -5.457 | 3.731 | Other |
| READ_MFCC 1st order delta 11 (The statistical data given below have exponential factor in addition to the values mentioned. For dispersion value it was 10^-5). | Mixed Models Analysis | 0.0471 | Slope | 0.0001893 | Standard Error of the Mean | 9.442 | 2-Sided | 90 | 0.00003283 | 0.0003458 | Other |
| READ_MFCC 1st order delta 12 (The statistical data given below have exponential factor in addition to the values mentioned. For dispersion value it was 10^-5). | Mixed Models Analysis | 0.0390 | Slope | 0.0001380 | Standard Error of the Mean | 6.614 | 2-Sided | 90 | 0.00002840 | 0.0002476 | Other |
| READ_MFCC 1st order delta 13 (The statistical data given below have (The statistical data given below have exponential factor in addition to the values mentioned. For upper limit, estimated value and dispersion value it was 10^-4. For lower limit it was 10^-5). | Mixed Models Analysis | 0.2645 | Slope | 1.166 | Standard Error of the Mean | 1.040 | 2-Sided | 90 | -5.579 | 2.890 | Other |
| READ_MFCC 2nd order delta 01 (The statistical data given below have exponential factor in addition to the values mentioned. For dispersion value it was 10^-4). | Mixed Models Analysis | 0.0420 | Slope | -0.001190 | Standard Error of the Mean | 5.790 | 2-Sided | 90 | -0.002149 | -0.0002303 | Other |
| READ_MFCC 2nd order delta 02 (The statistical data given below have exponential factor in addition to the values mentioned. For lower limit, estimated value and dispersion value it was 10^-4. For upper limit it was 10^-5). | Mixed Models Analysis | 0.1410 | Slope | -4.504 | Standard Error of the Mean | 3.040 | 2-Sided | 90 | -9.542 | 5.341 | Other |
| READ_MFCC 2nd order delta 03 (The statistical data given below have exponential factor in addition to the values mentioned. For upper limit, lower limit, estimated value and dispersion value it was 10^-4). | Mixed Models Analysis | 0.3751 | Slope | 2.968 | Standard Error of the Mean | 3.334 | 2-Sided | 90 | -2.557 | 8.492 | Other |
| READ_MFCC 2nd order delta 04 (The statistical data given below have exponential factor in addition to the values mentioned. For dispersion value it was 10^-4). | Mixed Models Analysis | 0.7053 | Slope | -0.0000796 | Standard Error of the Mean | 2.101 | 2-Sided | 90 | -0.0004277 | 0.0002685 | Other |
| READ_MFCC 2nd order delta 05 (The statistical data given below have exponential factor in addition to the values mentioned. For upper limit, lower limit, estimated value and dispersion value it was 10^-4). | Mixed Models Analysis | 0.0078 | Slope | 5.075 | Standard Error of the Mean | 1.878 | 2-Sided | 90 | 1.964 | 8.187 | Other |
| READ_MFCC 2nd order delta 06 (The statistical data given below have exponential factor in addition to the values mentioned. For lower limit, estimated value and dispersion value it was 10^-4. For upper limit it was 10^-6). | Mixed Models Analysis | 0.1119 | Slope | -1.880 | Standard Error of the Mean | 1.174 | 2-Sided | 90 | -3.826 | 6.611 | Other |
| READ_MFCC 2nd order delta 07 (The statistical data given below have exponential factor in addition to the values mentioned. For upper limit, estimated value and dispersion value it was 10^-4. For lower limit it was 10^-5). | Mixed Models Analysis | 0.1545 | Slope | 1.667 | Standard Error of the Mean | 1.164 | 2-Sided | 90 | -2.615 | 3.596 | Other |
| READ_MFCC 2nd order delta 08 (The statistical data given below have exponential factor in addition to the values mentioned. For upper limit and estimated value it was 10^-4. For lower limit it was 10^-6 and for dispersion value it was 10^-5). | Mixed Models Analysis | 0.1114 | Slope | 1.531 | Standard Error of the Mean | 9.552 | 2-Sided | 90 | -5.164 | 3.114 | Other |
| READ_MFCC 2nd order delta 09 (The statistical data given below have exponential factor in addition to the values mentioned. For dispersion value it was 10^-4). | Mixed Models Analysis | 0.0668 | Slope | 0.0001989 | Standard Error of the Mean | 1.076 | 2-Sided | 90 | 0.00002067 | 0.0003772 | Other |
| READ_MFCC 2nd order delta 10 (The statistical data given below have exponential factor in addition to the values mentioned. For dispersion value it was 10^-5). | Mixed Models Analysis | 0.5509 | Slope | 0.00005573 | Standard Error of the Mean | 9.318 | 2-Sided | 90 | -0.0000986 | 0.0002101 | Other |
| READ_MFCC 2nd order delta 11 (The statistical data given below have exponential factor in addition to the values mentioned. For dispersion value it was 10^-5). | Mixed Models Analysis | 0.8383 | Slope | 0.00001774 | Standard Error of the Mean | 8.677 | 2-Sided | 90 | -0.0001260 | 0.0001615 | Other |
| READ_MFCC 2nd order delta 12 (The statistical data given below have exponential factor in addition to the values mentioned. For dispersion value it was 10^-5). | Mixed Models Analysis | 0.2713 | Slope | 0.00007327 | Standard Error of the Mean | 6.630 | 2-Sided | 90 | -0.0000366 | 0.0001831 | Other |
| READ_MFCC 2nd order delta 13 (The statistical data given below have exponential factor in addition to the values mentioned. For dispersion value it was 10^-5). | Mixed Models Analysis | 0.0931 | Slope | 0.0001534 | Standard Error of the Mean | 9.067 | 2-Sided | 90 | 0.00000317 | 0.0003037 | Other |
MM_Entropy (The statistical data given below have exponential factor in addition to the values mentioned. For estimated value it was 10^-4. For dispersion value, lower limit and upper limit it was 10^-3).
| Mixed Models Analysis |
| 0.9587 |
| Slope |
| -1.479 |
| Standard Error of the Mean |
| 2.847 |
| 2-Sided |
| 90 |
| -4.866 |
| 4.570 |
| Other |
|
| EE_Formant 2 Bandwidth: LSM (10^-1), SE (10^0) |
|
| EE_Formant 3: LSM (10^-1), SE (10^-1) |
|
| EE_Formant 3 Bandwidth: LSM (10^-2), SE (10^0) |
|
| MM_Formant 1: LSM (10^-1), SE (10^-1) |
|
| MM_Formant 1 Bandwidth: LSM (10^-2), SE (10^0) |
|
| MM_Formant 2: LSM (10^-1), SE (10^0) |
|
| MM_Formant 2 Bandwidth: LSM (10^-1), SE (10^0) |
|
| MM_Formant 3: LSM (10^0), SE (10^0) |
|
| MM_Formant 3 Bandwidth: LSM (10^0), SE (10^0) |
|
EE_Formant 1 Bandwidth (The statistical data given below have exponential factor in addition to the values mentioned. For dispersion value it was 10^-1).
| Mixed Models Analysis |
| 0.9084 |
| Slope |
| -0.06912 |
| Standard Error of the Mean |
| 5.997 |
| 2-Sided |
| 90 |
| -1.063 |
| 0.9247 |
| Other |
| EE_Formant 2 (The statistical data given below have exponential factor in addition to the values mentioned. For upper limit, lower limit and dispersion value it was 10^0. For estimated value it was 10^-1). | Mixed Models Analysis | 0.8721 | Slope | 1.985 | Standard Error of the Mean | 1.230 | 2-Sided | 90 | -1.841 | 2.238 | Other |
| EE_Formant 2 Bandwidth (The statistical data given below have exponential factor in addition to the values mentioned. For dispersion value it was 10^0). | Mixed Models Analysis | 0.7647 | Slope | 0.6573 | Standard Error of the Mean | 2.191 | 2-Sided | 90 | -2.974 | 4.288 | Other |
| EE_Formant 3 (The statistical data given below have exponential factor in addition to the values mentioned. For dispersion value it was 10^-1). | Mixed Models Analysis | 0.4692 | Slope | 0.6504 | Standard Error of the Mean | 8.958 | 2-Sided | 90 | -0.8341 | 2.135 | Other |
| EE_Formant 3 Bandwidth (The statistical data given below have exponential factor in addition to the values mentioned. For dispersion value it was 10^0). | Mixed Models Analysis | 0.9400 | Slope | -0.09459 | Standard Error of the Mean | 1.255 | 2-Sided | 90 | -2.174 | 1.985 | Other |
| MM_Formant 1 (The statistical data given below have exponential factor in addition to the values mentioned. For dispersion value it was 10^-1). | Mixed Models Analysis | 0.3853 | Slope | 0.6945 | Standard Error of the Mean | 7.972 | 2-Sided | 90 | -0.6265 | 2.015 | Other |
| MM_Formant 1 Bandwidth (The statistical data given below have exponential factor in addition to the values mentioned. For dispersion value it was 10^0). | Mixed Models Analysis | 0.9811 | Slope | 0.02424 | Standard Error of the Mean | 1.021 | 2-Sided | 90 | -1.667 | 1.716 | Other |
| MM_Formant 2 (The statistical data given below have exponential factor in addition to the values mentioned. For dispersion value it was 10^0). | Mixed Models Analysis | 0.3944 | Slope | -0.9256 | Standard Error of the Mean | 1.083 | 2-Sided | 90 | -2.720 | 0.8690 | Other |
| MM_Formant 2 Bandwidth (The statistical data given below have exponential factor in addition to the values mentioned. For dispersion value it was 10^0). | Mixed Models Analysis | 0.4696 | Slope | 0.9350 | Standard Error of the Mean | 1.289 | 2-Sided | 90 | -1.201 | 3.071 | Other |
| MM_Formant 3 (The statistical data given below have exponential factor in addition to the values mentioned. For dispersion value it was 10^0). | Mixed Models Analysis | 0.0896 | Slope | 2.105 | Standard Error of the Mean | 1.231 | 2-Sided | 90 | 0.06596 | 4.145 | Other |
| MM_Formant 3 Bandwidth (The statistical data given below have exponential factor in addition to the values mentioned. For upper limit, estimated value and dispersion value it was 10^0. For lower limit it was 10^-1). | Mixed Models Analysis | 0.2227 | Slope | 1.664 | Standard Error of the Mean | 1.358 | 2-Sided | 90 | -5.864 | 3.915 | Other |
MM_Voiced Frames (The statistical data given below have exponential factor in addition to the values mentioned. For dispersion value it was 10^-4).
| Mixed Models Analysis |
| 0.4070 |
| Slope |
| -0.0006624 |
| Standard Error of the Mean |
| 7.961 |
| 2-Sided |
| 90 |
| -0.001982 |
| 0.0006569 |
| Other |
MM_Jitter Local (The statistical data given below have exponential factor in addition to the values mentioned. For upper limit, lower limit, and dispersion value it was 10^-3. For estimated value it was 10^-4).
| Mixed Models Analysis |
| 0.9447 |
| Slope |
| -2.206 |
| Standard Error of the Mean |
| 3.176 |
| 2-Sided |
| 90 |
| -5.483 |
| 5.042 |
| Other |
MM_Shimmer Local (The statistical data given below have exponential factor in addition to the values mentioned. For dispersion value it was 10^-2).
| Mixed Models Analysis |
| 0.5831 |
| Slope |
| 0.006060 |
| Standard Error of the Mean |
| 1.101 |
| 2-Sided |
| 90 |
| -0.01219 |
| 0.02431 |
| Other |
| Title | Measurements |
|---|---|
|
| Symptom and Voice Compliance |
|
|
| Self-swab 1: Flu B |
|
|
| Self-swab 1: RSV |
|
|
| Self-swab 1: SARS-CoV-2 and/or Influenza and/or RSV |
|
|
| Self-swab 2: SARS-COV-2 |
|
|
| Self-swab 2: Flu A |
|
|
| Self-swab 2: Flu B |
|
|
| Self-swab 2: RSV |
|
|
| Self-swab 2: SARS-CoV-2 and/or Influenza and/or RSV |
|
|
|
|
|
| Positive or negative self-swab 1 result for Flu B |
|
|
| Positive or negative self-swab 1 result for RSV |
|
|
| Positive or negative self-swab 2 result for SARS-CoV-2 |
|
|
| Positive or negative self-swab 2 result for Flu A |
|
|
| Positive or negative self-swab 2 result for Flu B |
|
|
| Positive or negative self-swab 2 result for RSV |
|
|